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 Chapter 1
General introduction
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The more I learn, the more I realize how much I don’t know
– Albert Einstein
Meniscal surgery has been a default treatment for meniscal tears for generations of clinicians 
and patients; it remains the most frequently performed orthopedic procedure worldwide. 
In recent years, however, advances in imaging as well as clinical and biomechanical studies 
have led to progressive insights into the meniscus’ major biomechanical function. The more 
we have learned about the meniscus, the more questions have been raised regarding the 
etiology of meniscal pathology, the efficacy of current treatments, and the optimal imaging 
techniques.
The meniscus: anatomy and function
The menisci are two fibrocartilaginous structures interposed between the femoral condyles 
and the tibial plateau (Figure 1). The word ‘’meniscus’’ is derived from the Ancient Greek 
term for moon, mene, referring to its half-moon shape (Figure 2-A, 2-B). Each human knee 
contains two menisci: one in the medial (i.e., medial meniscus) and one in the lateral (i.e., 
lateral meniscus) joint compartment (Figure 2-A). Both menisci are wedge-shaped in cross 
section (Figure 2-C). The peripheral base of the medial meniscus is tightly attached to the 
joint capsule (Figure 2-C), whereas the attachment of the lateral meniscus is more mobile. 
A disruption in the attachment of the capsule to the lateral meniscus, the so-called popliteal 
hiatus, permits the popliteal tendon to pass through 1. In addition, both menisci are attached 
to the tibial plateau via the anterior and posterior roots. The tibial attachments of the lateral 
meniscus are placed more centrally (in an anterior-posterior view) than the tibial attachments 
of the medial meniscus, resulting in the lateral meniscus being less fixed than the medial 
meniscus (Figure 2-A) 1-6.
Figure 1. Anatomy of the human menisci. 
Right knee, frontal view, patella removed. 
Knee is slightly flexed. Medial and lateral me-
nisci are highlighted in red. Artwork by the 
author.
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A B C
Figure 2. Attachments of the menisci. A) Left cadaveric knee joint, top view, femur removed. Note 
the difference in tibial attachments of meniscal roots between medial (red stars) and lateral (blue stars) 
meniscus. B) Medial meniscus, ex vivo, obtained during upper leg amputation in a 53-year-old male 
with no previous history of knee injury. C) Cross section of cadaveric medial knee compartment in 
coronal plane at the level of the medial collateral ligament (white arrows). Abbreviations: MM = medial 
meniscus; LM = lateral meniscus; ACL = anterior cruciate ligament; PCL = posterior cruciate ligament; 
PT = patellar tendon; MCL = medial collateral ligament; MFC = medial femoral condyle; MTC = medial 
tibial condyle. Pictures 2-A and 2-C by dr. U. Zdanowicz, from Surgery of the Meniscus, Springer 2016; 
reproduced with permission.
Figure 3. Cross-sectional view of the meniscus showing its collagen fiber configuration. A) 
Tightly woven superficial mesh layer. B) Radially oriented collagen fibers. C) Circumferentially oriented 
collagen fibers. Artwork by the author.
The meniscus contains 70% water and 30% organic matter. Collagen (mainly type 1) 
accounts for 75% of the dry mass 2,7,8. Menisci consist of firmly woven collagen fibers, 
mostly arranged in a circumferential pattern. Some of the fiber bundles in the central zone 
and superficial layers are radially aligned (Figure 3). This specific pattern of fiber orientation 
provides strength and the ability to convert compression load into tensile stress 2,9-11. The 
vascular supply is derived from branches of the inferior and superior geniculate arteries, 
infiltrating the peripheral zones of the menisci (often called the “red zone”). The central third 
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of the meniscus is avascular in adults (often called the “white zone”) and receives nutrients 
by diffusion of synovial fluid 2,12,13.                      
Although described as ‘’irrelevant remains of leg muscle’’ in the past 14, it is now clear that 
the menisci have an important biomechanical function in the knee. Their primary function is 
shock absorption and load distribution across the tibiofemoral joint (Figure 4). The menisci 
transmit and distribute at least 50-70% of the total load when the knee is in extension and 
85-90% when in flexion 15,16. Moreover, they have a role in stabilization and fluid distribution 
within the knee joint 11,17-21.
A B
Figure 4. Biomechanical function of the meniscus. Schematic view of the knee joint in sagittal plane, 
in absence (A) and in presence (B) of the meniscus. The menisci, highlighted in red, distribute compres-
sive load (blue arrows) and decrease contact stress force throughout the knee joint.
Meniscal pathology: incidence and etiology
With a general incidence of 60-70 per 100.000 individuals per year, a meniscal tear is among 
the most common types of knee injury 22-24. Clinical presentation may include knee pain, me-
chanical symptoms (i.e., locking complaints) and, in many cases, significant disability, thereby 
creating a great burden for patient and society 24. Meniscal tears are traditionally classified 
into two main categories: traumatic versus degenerative tears. This classification is mainly 
based on onset of complaints (i.e., traumatic or degenerative); however, the patient’s age 
and other pathological findings in the knee (e.g., osteoarthritis and injury of other ligaments, 
such as anterior cruciate ligaments) play a role as well 1,17,24-27.
Traumatic meniscal tears have an acute onset, most often seen in young, active individuals 
and mostly as a result of twisting injuries. This often occurs during sports activities (soccer 
and field hockey are high-risk sports); however, traumatic meniscal tears resulting from minor 
accidents in daily life are also common. Combined traumatic injuries of the (mostly lateral) 
meniscus and anterior cruciate ligament are frequently observed 28,29. Traumatic tears are 
often oriented in the longitudinal or oblique direction, running parallel to the circumferen-
tially arranged collagen fibers, although various other tear patterns are possible as well 1,30-32. 
Traumatic meniscal tears can be subdivided into 1) obstructive and 2) non-obstructive tears. 
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An obstructive tear is when the torn part of the meniscus is (partly) dislocated, resulting in 
‘’locking’’ of the knee. The remaining cases are non-obstructive tears 33.
In contrast to traumatic tears, degenerative meniscal tears develop gradually. These tears 
are often seen in the middle-aged or the elderly, as a result of repetitive normal forces acting 
upon a meniscus with already ongoing degenerative tissue changes 1,26. Degenerative tears 
are typically horizontal cleavage lesions and is often associated with pre-existing cartilage 
degeneration 25,34. Increasing evidence suggests that a symptomatic degenerative menis-
cal tear is not an isolated entity but a sign of knee osteoarthritis (OA) 1,18,35; however, this 
does not necessarily mean that pain symptoms in a patient with a degenerative tear in an 
osteoarthritic knee are caused by the meniscal damage. The prevalence of degenerative 
meniscal tears, as detected on magnetic resonance imaging (MRI) in the general population 
above 70 years old, is about 45% 36. Remarkably, 60% of these degenerative tears on MRI 
are asymptomatic 36 and, therefore, can be considered incidental findings on knee MRI. The 
biological mechanism leading to degenerative meniscal tears and the complex role of the 
meniscus in the pathological process in knee OA are still largely unknown.
(Mr) imaging of meniscal pathology
Since its introduction in the 1980s, conventional MRI has been the gold standard for me-
niscus imaging in clinical practice and research 1. A great advantage of MRI is that multiple 
relevant knee structures, such as menisci, cartilage, and synovium, can be assessed within 
one examination 37. For detecting meniscal tears, in general, spin echo based proton-density 
(PD) weighted sequences with an echo time around 35 ms and long repetition time, in 
the sagittal and coronal plane, are considered most appropriate (Figure 5-A)38. If performed 
correctly, MRI can detect a meniscal tear accurately in > 90% of the cases 26,39-41.
Meniscal damage on MRI may comprise the following: 1) tissue degeneration (intra-sub-
stance alterations, measured by increased signal intensity or T2 relaxation times); 2) meniscal 
extrusion (i.e., radial displacement of the meniscus); and 3) morphological damage, that is, 
meniscal tears or maceration42-45. A meniscal tear is usually characterized by a linear intra-
meniscal signal communicating with the meniscal surface. Maceration means a completely 
worn-down meniscus, defined as loss of morphological substance of the meniscus on MRI 46.
In a clinical setting, radiologists usually describe meniscal tears in free text. In clinical 
research, on the other hand, a more standardized approach, in terms of reproducibility, is 
needed. Several semiquantitative MRI classification systems for the knee, such as the MRI 
Osteoarthritis Knee Score (MOAKS) 46, have been developed for this purpose. In these clas-
sification systems, MRI findings of multiple knee structures, including cartilage and menisci, 
are scored.
Although sensitive to alterations of meniscal morphology, conventional MRI has limited 
capability to detect early changes in the meniscus before gross morphological abnormalities 
occur. This hampers early therapeutic interventions and disease monitoring. To overcome 
13
 
this limitation, quantitative MRI (qMRI) techniques (sometimes referred to as compositional 
or molecular MRI techniques), such as T2 mapping (Figure 5-B), T1rho, and ultra-short echo 
time T2* mapping (UTE-T2*), have been developed 47-54. By quantitatively assessing key bio-
chemical meniscus components – collagen and proteoglycans –, qMRI techniques allow the 
detection of early stages of meniscal degeneration and accurate follow-up 47,55-57. Moreover, 
they allow a refi ned grading of meniscus pathology, increasing the discriminative power to 
distinguish degrees of meniscus degeneration 47,57. Among qMRI techniques, T2 mapping is 
the most widely used in the fi eld of musculoskeletal research 37,58,59.
The main advantage of T2 mapping is that its implementation is relatively easy, as (contrary 
to most other qMRI techniques) no contrast or special MR hardware is required. What exactly 
is measured with T2 mapping remains controversial, yet most researchers agree that increased 
T2 relaxation times indicate an increased mobility of water protons as a result of damage to 
the collagen matrix of the meniscus. Matrix degradation may refl ect tissue degeneration, 
thus providing an indirect measure for biochemical composition 54,57,60-62.
Before qMRI techniques, such as T2 mapping, can fi nd their way to clinical practice, thor-
ough assessment of its accuracy (i.e., do we measure what we want to measure?), reliability 
(i.e., are measurements reproducible?) and feasibility (e.g., what are the technical require-
ments? And is the acquisition time acceptable?).
 
 
 
 
 
 
 
 
 A B 
Figure 5. Mr imaging of the meniscus. A) Sagittal Proton-Density weighted image, medial compart-
ment, anterior and posterior meniscal horns (yellow arrows) depicted as black triangles. B) Sagittal T2 
mapping image with colourmap of the posterior horn of the lateral meniscus.
Treatment of meniscal pathology
Treatment options for meniscal tears comprise non-operative and operative approaches. 
The choice of treatment strategy (i.e., non-operative or operative) depends upon the onset 
of complaints (i.e., traumatic or degenerative), the nature and extent of complaints, type 
and location of the meniscal tear, the presence of signifi cant mechanical symptoms (i.e., 
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locked knee), and the presence of additional knee pathology 33,63,64. Non-operative treatment 
comprises pain medication, relative rest and exercise therapy. The main goals of exercise 
therapy for meniscal tears are to reduce hydrops, to optimize range of motion, to increase 
muscle coordination and strength, and to restore knee function 65. Operative options to treat 
meniscal tears include arthroscopic partial meniscectomy (APM) or, in some cases, meniscal 
repair 1,66,67. APM means removing the torn part of the meniscus; repair means suturing the 
tear. Whether a meniscal tear is suitable for repair depends on the type of tear, tear length, 
and location of the tear, assessed on MRI 68-70. Longitudinal tears in the vascularized portion 
(i.e., the “red zone”) of the meniscus have the highest chance of success in the context of 
meniscal repair 1,69. The growing awareness of the major biomechanical function within the 
knee joint has led to an increasing interest in meniscal repair, yet only about 5% of meniscal 
tears are sutured 68.
For the treatment of degenerative tears, the European Society of Sports Traumatology, Knee 
Surgery and Arthroscopy (ESSKA) reached a consensus in 2016, based on clinical studies. The 
ESSKA recommends starting with non-operative treatment for at least 3 months, ‘’except in 
the case of considerable mechanical symptoms’’. If this approach fails, and no signs of OA are 
seen on radiograph or MRI, arthroscopic partial meniscectomy may be indicated 63.
Regarding traumatic meniscal tears, there is little consensus on treatment strategy. Accord-
ing to the guideline ‘’arthroscopy of the knee’’ of the Dutch Orthopedic Society, a traumatic 
tear in a “fixed locked knee” is an indication for arthroscopy within two weeks 64. For all 
remaining cases, no recommendation can be given as no sufficient evidence is available. 
In most cases, an APM or repair is chosen, despite of the fact that no evidence is avail-
able regarding operative versus non-operative therapy for traumatic tears. To fill this gap, in 
Erasmus MC University Medical Center, we designed a randomized controlled trial (RCT) to 
compare APM with non-operative treatment in patients with traumatic tears: the STARR trial.
AiMS AND oUTLiNE oF THiS THESiS
The STArr trial
The STARR trial is a multicenter open-labeled RCT, with eight participating hospitals (e.g. 
Máxima MC Eindhoven and Haaglanden MC Leidschendam), funded by the Dutch govern-
ment, comparing APM (resection, not repair) with standardized exercise therapy. In total, 
100 patients under 45 years without knee OA are included, with selection based on a 
solitary meniscal tear and acute onset, without a ‘’fixed locked knee’’. Locking complaints, 
in general, are not an exclusion criterium. Patients are followed for two years to investigate 
the differences between APM and exercise therapy with regard to 1) clinical effects (pain 
and function of the knee), 2) early cartilage degeneration using T2 mapping MRI, and 3) 
cost-effectiveness. MRI with T2 mapping is acquired in STARR patients at baseline and after 
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two years follow-up to assess early cartilage degeneration, as indicator for early-stage knee 
OA. Although the inclusion of patients already has finished, the follow-up of the STARR trial 
is currently still ongoing. The outcomes of the STARR trial will be available at the end of 2020; 
therefore, the results are not included in this thesis.
In the context of the STARR trial, several gaps in knowledge and research questions were 
identified concerning various aspects of meniscal pathology. The drive to answer those ques-
tions and to improve patient care was the basis of a number of research projects, the results 
of which are described in this thesis. This thesis is divided into two main themes: I) MR 
imaging and II) etiology and treatment of meniscal pathology.
PART I: MR IMAGING OF MENISCAL PATHOLOGY
How accurate is in vivo T2 mapping to assess meniscal degeneration?
T2 mapping, a quantitative MR imaging technique associated with tissue matrix degrada-
tion, is used in the STARR trial to measure cartilage degeneration after two years follow-up. 
Cartilage T2 mapping has been widely studied and has been shown to be associated with 
cartilage degeneration 61,71. Meniscal T2 mapping is relatively new 47,57. In order to use T2 
mapping as an imaging biomarker for meniscal degeneration in research and, eventually, 
in clinical practice, establishing its validity is essential. Validity of a technique means: does 
it measure what it is supposed to measure? Validation studies for meniscal T2 mapping are 
limited; moreover, studies assessing in vivo meniscal T2 mapping compared to histology have 
not yet been performed. Therefore, in this study, meniscal in vivo T2 mapping was validated 
against the histological degree of degeneration, using meniscal tissue from patients with 
knee OA. The results are described in Chapter 2.
What is the reproducibility of T2 mapping in a multicenter setting, such as 
the STArr trial?
The STARR trial is a multicenter study in which eight hospitals with, in total, 13 locations 
participate. In each of these hospitals, a ‘’STARR MRI protocol’’ (comprising routine clinical 
knee sequences and T2 mapping) was implemented. To interpret T2 mapping data from all 
these hospitals, information on multicenter comparability and longitudinal reproducibility is 
essential. Therefore, we performed a prospective pilot study to assess longitudinal reproduc-
ibility of cartilage T2 mapping in a multicenter setting. The results of this study are described 
in Chapter 3 and will be important for the analysis and interpretation of the results from the 
STARR trial in which T2 values are an outcome measure as an indicator for early OA.
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How can efficiency in Mri acquisition be improved?
T2 mapping and other qMRI techniques are promising tools to non-invasively assess joint 
health, yet efficient acquisition is challenging. Current MRI protocols for the knee, includ-
ing routine clinical sequences and a T2 mapping sequence, are time consuming: they take 
30-45 minutes 57,72. Recently, the quantitative double-echo steady-state (qDESS) sequence 
was developed to increase acquisition efficiency. qDESS provides quantitative measures of 
cartilage and meniscus and diagnostic image quality in a single MRI scan with a scan time of 
only five minutes. qDESS comprises two echoes, and the combined signal of the two echoes 
can generate T2 values. The sagittal qDESS images can be reformatted into coronal and axial 
reconstructions, thus, creating a 3D view of the knee. In collaboration with the Joint and 
Osteoarthritis Imaging with Novel Techniques (JOINT) lab of the Department at Radiology of 
Stanford University, we validated this relatively new and interesting sequence in OA patients. 
The results of this qDESS validation study are described in Chapter 4.
PART II: ETIOLOGY AND TREATMENT OF MENISCAL PATHOLOGY
The role of meniscal pathology in knee oA: cause or consequence?
As described earlier, the complex role of the meniscus in the development of knee OA is 
largely unknown. An important question in the etiology and disease development of knee 
OA concerns cartilage versus meniscus degeneration: what comes first in OA? To explore the 
temporal sequence of events in knee OA, a histology-based study in a mouse model for OA 
was performed as described in Chapter 5.
is the classification “traumatic” versus “degenerative” meniscal tears as 
straightforward as assumed?
Or is it more like a continuum: are traumatically torn menisci already more or less degen-
erative? The complex role of meniscal tissue composition in the etiology of meniscal tears 
and the subsequent development of knee OA is not entirely clear. To test the “continuum 
hypothesis”, we performed a cross-sectional histology-based observational study comprising 
different types of meniscal tissue. The results of this study are described in Chapter 6.
Clinical decision making in meniscal pathology: Should a traumatic 
meniscal tear be resected? - The STArr trial
The design of the STARR trial, a multicenter RCT in which APM is compared to conservative 
treatment in patients with traumatic meniscal tears, can be found in Chapter 7.
17
 
Clinical decision making in meniscal pathology: What are prognostic 
factors for outcome after APM?
It seems that there is a shift occurring regarding the treatment of meniscal tears: from “APM 
as standard of care’’ towards a more evidence-based approach of clinical decision making. 
Besides large clinical trials such as the STARR trial, evidence-based medicine also comprises 
an ‘’evidence-based patient selection’’ for APM. The identification of a subpopulation of 
patients with meniscal pathology who would likely benefit the most from APM requires 
knowledge of prognostic factors for the outcome after APM. To gain more insight into these 
prognostic factors, we performed a systematic literature review, as described in Chapter 8.
In Chapter 9, a general discussion regarding the study results in this thesis is provided. 
Clinical relevance, implications for research and clinical practice, future perspectives, and 
recommendations for further research are described. Chapter 10 comprises a general sum-
mary of the studies and study results in this thesis.
Chapter 1
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AbSTRACT
objective: To evaluate in vivo T2 mapping as quantitative, imaging-based biomarker for 
meniscal degeneration in humans, by studying the correlation between T2 relaxation time 
and degree of histological degeneration as reference standard.
Methods: In this prospective validation study, conducted from April 2016 to July 2017, 13 
menisci from seven patients with radiographic knee osteoarthritis (median age 67 year, three 
males) were included. Menisci were obtained during total knee replacement surgery. All 
patients underwent pre-operative magnetic resonance imaging using a 3-Tesla MR scanner 
which included a T2 mapping pulse sequence with multiple echoes. Histological analysis of 
the collected menisci was performed using the Pauli score, involving surface integrity, cel-
lularity, matrix organization, and staining intensity. Mean T2 relaxation times were calculated 
in meniscal regions of interest corresponding with the areas scored histologically, using a 
multi-slice multi echo postprocessing algorithm. Correlation between T2 mapping and histol-
ogy was assessed using a Generalized Least Squares model fit by maximum likelihood.
results: The mean T2 relaxation time was 22.4 ± 2.7 ms (range 18.5-27). The median histo-
logical score was 10, IQR 7-11 (range 4-13). A strong correlation between T2 relaxation time 
and histological score was found (rs = 0.84, 95%CI [0.64-0.93]).
Conclusion: In vivo T2 mapping of the human meniscus correlates strongly with histological 
degeneration. T2 mapping enables the detection and quantification of compositional changes 
of the meniscus, providing a non-invasive imaging biomarker for early knee OA.
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INTRODuCTION
The fascinating role of the meniscus in knee osteoarthritis (OA) has attracted considerable 
attention among researchers for decades. Not only is meniscal damage a radiological sign of 
OA -up to 91% of the patients with symptomatic knee OA have coexisting meniscal tears 1-, 
a torn meniscus is also one of the strongest risk factors for the development and progression 
of knee OA 2-5. Although the complex role of meniscal tissue composition in the etiology 
of meniscal tears and the subsequent development of knee OA is not entirely clear, it has 
become increasingly evident that the menisci play a critical role in the long-term health of 
the knee joint.
Hence, the ability to objectively assess meniscal tissue quality and composition is of key 
importance, particularly in patients at risk for developing knee OA 2. In order to study the 
etiology of meniscal tears and meniscal degeneration in knee OA development and progres-
sion, and to allow early interventions and prevention of progression, changes in meniscal 
tissue composition need to be detected before gross morphological changes occur.
Using conventional magnetic resonance (MR) imaging, measuring such changes in menis-
cal tissue composition prior to surface breakdown, is challenging. Recent developments in 
quantitative MR imaging techniques have made great progress in addressing this challenge 6,7. 
Among quantitative MR imaging techniques, T2 mapping is the most commonly used in knee 
OA research 8,9. Based on properties of biochemical tissue components, quantitative analysis 
of T2 relaxation times can reveal the composition of extracellular matrix, without the need 
for contrast or special MR hardware 6,10. Increased T2 relaxation times indicate damage to the 
collagen network and a decrease in water content, both signals of tissue degeneration 11.
Recent studies have shown the potential of T2 relaxation time as biomarker to quantify 
meniscal degeneration in patients with knee OA 6,12-14, yet validation studies of meniscal T2 
mapping are limited. Validation of T2 mapping, using histological analysis; the gold standard 
for tissue changes, was performed in one previous study 7. In that study, T2 mapping was 
performed ex vivo, however it is unknown how well T2 measurements, obtained ex vivo, 
reflect the actual in vivo situation. To our knowledge, validation of in vivo meniscal T2 map-
ping, using histological analysis as reference test, has not been performed.
We aimed to validate in vivo meniscal T2 mapping in patients with knee OA by evaluat-
ing the correlation between T2 mapping and histological reference standards for meniscal 
degeneration.
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METHODS
Study design and participants
Our prospective observational study was conducted between April 2016 and July 2017. 
Meniscal specimens were obtained from patients with primary end-stage knee OA under-
going elective total knee replacement surgery at our institution. Participants were selected 
consecutively. Study approval was granted by the institutional Medical Ethical Committee 
(MEC-2012-218), and written informed consent was obtained from all participants.
Assessment of radiographic knee oA
The assessment of radiographic knee OA is described in Supplementary Material 1.
Mr image acquisition
MR imaging was performed on a 3 Tesla (T) MR unit (Discovery MR750, GE Healthcare, Mil-
waukee, USA), 1 day prior to surgery. The MR imaging protocol included routine morphologi-
cal knee sequences (Proton Density weighted sequences in sagittal, coronal and axial plane, 
T2 weighted sequences with Fat Saturation (Fat-Sat) in sagittal, coronal and axial plane) and 
a sagittal 3D Fat-Sat fast spin echo (FSE) T2 mapping sequence with multiple echoes. A 
8-channel Send&Receive rigid dedicated knee coil (GE Healthcare, Milwaukee, WI, United 
States) was used. Sequence parameters are displayed in Table 1.
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Harvesting of meniscal tissue and histological analysis
Meniscal specimens were obtained intra-operatively, during total knee replacement surgery. 
If present, both medial and lateral menisci were harvested, meniscal samples were stored 
in formaldehyde. Within three days of harvesting, menisci were cut in a standardized way 
according to Pauli et al. 15 (Figure 1). For each meniscus, the anterior horn and the posterior 
horn were processed. The menisci were cut at 45° (for the anterior horn) and 135° (for the 
posterior horn) angles relative to the sagittal plane (Figure 1-A). Meniscal samples were cut 
along two different planes: the vertical plane and the horizontal plane. The vertical section 
provided an overview of the longitudinally oriented collagen bundles and the tibial and 
femoral surfaces of the meniscus (Figure 1-C). The horizontal section, cut from the inner 
rim to the vascular zone at a 30° angle relative to the tibial plateau, revealed the parallel 
organization of the collagen bundles and matrix morphology (Figure 1-B).
The samples were fixed, dehydrated in alcohol, and infiltrated with paraffin. Next, menis-
cal samples were paraffin-embedded and sectioned using a microtome (MR2235, Leica-
Biosystems, Wetziar, Germany) into six-micrometer sections.
To provide an overview of the overall tissue organization, and to assess border integrity, 
cellularity, and cell morphology, sections were stained using Hematoxylin and Eosin. Safranin 
O-Fast Green and Alcian Blue stain were used to evaluate proteoglycan content and mucoid 
degeneration, respectively. To assess collagen fiber organization, Picrosirius Red stain was 
used. Stained sections were visualized using (polarized-) light microscopy (Olympus-BX50, 
Olympus-Optical, Shinjuku, Tokyo) 16. To assess the histological degree of degeneration, the 
validated, semi-quantitative Pauli score 15 was performed by two investigators with four 
years of experience in musculoskeletal research (Table 2). Both investigators were blinded to 
patient information and imaging outcomes. They examined all meniscal samples individually; 
in case of discrepancies, sections were assessed in consensus.
Quantitative Mr image analysis
On T2 mapping images, meniscal regions of interest (ROIs) were manually segmented by a 
researcher with a medical degree and four years of experience in musculoskeletal research 
(Figure 2), who was blinded to patient information and histology outcomes. Meniscal seg-
mentation was performed using an image collected with the echo time (TE) showing optimal 
contrast between menisci and surrounding tissues (TE 7.3 ms).
Great care was taken to match MR imaging ROIs and histological ROIs. As described earlier, 
histological tissue processing was performed using predefined anatomical regions; the most 
central part of the anterior horn and the most central part of the posterior horn. As histologi-
cal samples were cut in a fixed and standardized way, MR imaging ROIs were matched to 
histological ROIs. To do so, we identified the most central slice through the medial and lateral 
meniscus (defined as the sagittal slice depicting the maximum width of the anterior horn and 
posterior horn as individual triangles) along with the neighboring slices medially and laterally. 
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Four ROIs were defined per patient: the anterior and posterior horn of the medial and lateral 
meniscus. All ROIs consisted of three consecutive slices: the most central slice along with the 
adjacent slice medially and laterally. MR imaging scout views, using T2 weighted images in 
the coronal and axial plane, were used to verify that the ROIs were correctly defined (i.e. that 
they matched histological ROIs).
For MR image post-processing, in-house developed registration and fitting algorithms in 
Matlab (R2011a; The MathWorks, Natick, Mass) were used 17. Automated rigid registration 
in 3D was used for motion compensation 17. Similar to previous studies 18,19, we excluded all 
images with TE above 30 ms because of the very low signal-to-noise-ratio in meniscal tissue 
(Table 1). To reduce effects of possible outliers within ROIs, T2 relaxation times were weighted 
by the reciprocal of the uncertainty of the estimated T2 relaxation time in each voxel. This 
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uncertainty was measured with the square root of the Cramer-Rao lower bound, which gives 
a lower bound for the standard deviation of the estimated T2 relaxation time 17. The weighted 
T2 mapping relaxation times for each ROI were averaged over the three consecutive MR 
imaging slices, further referred to as mean T2 relaxation time 17.
Figure 2. Segmentation of the meniscus. Representative example of sagittal T2 mapping image with 
manually drawn region of interest (ROI) of the posterior horn of the lateral meniscus in a 67-year-old 
female with knee osteoarthritis.
Figure 1. Preparation of meniscal samples. Example of a grossly intact lateral meniscus harvested 
during total knee arthroplasty in a left knee of a 59-year-old female with medial compartment knee OA 
(Kellgren and Lawrence grade 4). A) Cutting the meniscus according to the method of Pauli et al; vertical 
cut. B) Horizontal cut, from the inner rim to the vascular zone at a 30° angle relative to the tibial plateau. 
C) Detail view of vertical cut of the posterior horn.
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Statistical analysis
Descriptive statistics for all available variables, including demographics, T2 relaxation times 
per meniscal ROI, and histological scores, are reported. Normality was tested using Shapiro-
Wilk tests. Normally distributed data were presented as mean with standard deviation; non-
normally distributed data were presented as median with inter quartile range (IQR).
Inter-observer reliability of histological scoring was tested using two-way intraclass correla-
tion coefficients (ICCs) of absolute agreement, taking single measurements.
We performed a linear mixed-effects model to assess the correlation between T2 relaxation 
times and histological scores, where T2 relaxation times were considered as dependent vari-
able and histological score as independent variable. We employed Generalized Least Squares 
function in the “nlme”-library in the statistical software “R” 20 allowing to calculate the corre-
lation in repeated measures data (i.e. in datasets that include multiple measures per patient). 
Age, BMI, and sex were tested as potential covariates since they might impact T2 values. A 
backward variable selection and the likelihood ratio test were used for this purpose. Subgroup 
analyses were performed using a linear mixed-effects model, regarding regional differences.
Statistical analyses were performed using R version 3.4.2 (2017) 20.
RESuLTS
Patient characteristics
In total, 13 menisci were collected from 7 patients with knee OA; six medial and seven 
lateral menisci. There was a slight overall female predominance of 57%, the median age of 
patients was 67 years (range 59-74). None of the menisci showed a macroscopic tear. Patient 
characteristics are shown in Table 3.
radiographic knee oA
Patients had either moderate radiographic knee OA (KLG 3, n = 3) or severe radiographic 
knee OA (KLG 4, n = 4).
T2 relaxation time in meniscal tissue
The mean meniscal T2 relaxation time was 22.4 ± 2.7 ms (range 18.5-27). In addition to 
overall mean T2 relaxation times (i.e. the mean of measurements from all ROIs), mean T2 
relaxation times were calculated for the four meniscal ROIs (medial anterior and posterior, 
lateral anterior and posterior) separately, reported in Table 4. Highest T2 relaxation times were 
found in the medial anterior horn of the meniscus. Statistical significantly higher T2 relaxation 
times were found in the medial menisci than in the lateral menisci (P = 0.005). No statistically 
significant differences between the anterior and posterior meniscal horns in T2 relaxation time 
were found (P = 0.14). Representative T2 mapping findings are displayed in Figure 3-I – 3-J.
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Histological findings in meniscal tissue
In two patients, all four meniscal regions (medial anterior, medial posterior, lateral anterior 
and lateral posterior) could be harvested. In the remaining five patients, as a result of partial 
maceration of the menisci due to end-stage knee osteoarthritis, not all four regions could be 
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Figure 3. representative images of histological findings and corresponding T2 mapping im-
ages. A, C, E, G) Posterior horn of lateral meniscus of a 67-year-old female with knee OA (Kellgren and 
Lawrence grade 3), with a mean T2 relaxation time of 18.6 ms and a histological score of 5. B, D, F, H) 
Posterior horn of medial meniscus of a 66-year-old female with knee OA (Kellgren and Lawrence grade 
4) with a mean T2 relaxation time of 26.9 ms and a histological score of 13. A, B) Surface integrity (HE 
staining, 10 x zoom). C, D) Cellularity (HE staining, 40 x zoom). E, F) Collagen organization (Picrosirius-
Red staining, 5 x zoom). G, H) Collagen matrix staining intensity, a decreased intensity of green stain-
ing indicates disruption in collagen matrix (Saf-O-Green staining, 10 x zoom). I, J) Corresponding non-
contrast sagittal T2 mapping images with color map of the meniscus. The color bar on the right shows 
the range of T2 values.
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harvested (only three regions possible in four patients and a single region in one patient). In 
total, 21 meniscal regions were used for histological analysis.
The inter-observer reliability of histological scoring between the two observers was excel-
lent (ICC: 0.95, 95%CI [0.79-0.99]). We found an overall median histological score of 10, 
IQR 7-11 (range 4-13). Mean histological scores per meniscal ROI are shown in Table 4. As 
for T2 relaxation times, the highest histological scores were found in the medial anterior horn 
of the meniscus and histological scores were found to be higher in the medial menisci than 
in the lateral menisci (P = 0.007). Also, no statistically significant differences between the 
anterior and posterior meniscal horns in histological score were found (P = 0.20). Representa-
tive histological findings are displayed in Figure 3-A - 3-H.
Correlation between T2 mapping and histological scores
In the linear mixed-effects model, the variables age, sex and BMI were not statistically sig-
nificant and were excluded from the model. To incorporate the potential effect of repeated 
measures (i.e. multiple measures per patient), the model has been statistically adjusted. A 
strong correlation between T2 mapping and histology (correlation coefficient 0.85, 95%CI 
[0.68-0.93]) was found.
DISCuSSION
In this study, we assessed the correlation between in vivo meniscal T2 mapping and histology 
in patients with radiographic knee OA. We demonstrated that meniscal T2 relaxation times in 
patients with knee OA show a strong correlation with the degree of histological degenera-
Figure 4. Scatterplot of histological scores versus T2 relaxation times, in all patients and all mea-
surements.
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tion. These findings indicate the potential of T2 relaxation times, obtained with in vivo T2 
mapping, as non-invasive imaging biomarker for meniscal degeneration.
The results of our study are in line with those of previous research on meniscal T2 map-
ping where no histological analysis was performed. These studies showed that T2 mapping 
can differentiate between healthy patients and those with knee OA. Zarins et al. found 
that meniscal T2 mapping discriminated between healthy and severe OA, but not between 
healthy and mild OA, and only in the posterior meniscal horns 19. Rauscher and colleagues 
reported that T2 mapping discriminated between healthy, mild and severe OA in all meniscal 
regions 13. In addition to OA patients, T2 mapping has been investigated in patients with 
acute knee injury. Significantly higher T2 relaxation times were reported in patients with an 
anterior cruciate ligament rupture, compared to healthy controls 12.
To our knowledge, this is the first study to investigate the validity of in vivo meniscal T2 
mapping in osteoarthritic patients, using histology as the reference test. Recently, Nebelung 
et al. performed a validation study of multiple quantitative MR imaging techniques, including 
T2 mapping 7. Histological analysis of meniscal samples from total knee replacement surger-
ies was used as the reference standard. In contrast to the present study, their T2 mapping 
measurements were performed ex vivo. Whether T2 measurements, obtained ex vivo, reflect 
the actual in vivo situation, could be questioned. Several factors in ex vivo experiments may 
affect T2 relaxation times. First, storage of meniscal samples in medium and changes in tissue 
hydration may have potentially affected T2 measurements 7,14. Second, in ex vivo experiments, 
samples are typically scanned at room temperature and not at body temperature, potentially 
influencing T2 relaxation times. Last, ex vivo quantitative MR imaging experiments usually 
have different acquisition parameters, such as the number and duration of echo times, field 
of view, and acquisition matrix, compared with in vivo 7,21. These factors may have caused 
the lower correlation coefficient (r: 0.65) between T2 mapping and histology in their study 
compared to ours.
In musculoskeletal imaging research, T2 mapping was originally developed for the quantifica-
tion of articular cartilage, yet T2 relaxation times have been increasingly used to assess menis-
cal tissue composition 7,13,14,19. It is suggested that meniscal T2 mapping can be challenging 
due to the short T2 components and the heterogeneity of meniscal tissue 22,23. In previous 
studies, concerns have therefore been raised that standard spin echo based T2 mapping is not 
suitable to quantitatively measure the menisci 24. The results of the present study, however, 
suggest that in vivo spin echo based T2 mapping can provide accurate T2 measurements in 
menisci. An important advantage of T2 mapping is that it has the potential to quantitatively 
assess a variety of knee tissues; as the range of echo times in T2 mapping is usually wide 25,26. 
Quantitative MR imaging techniques that obtain extremely short echo times, such as Ultra-
short echo time-enhanced T2* (UTE-T2*) are less suitable for the assessment of, for example, 
superficial layers of articular cartilage, due to their higher T2 signal 6,27. Taking into account 
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that knee OA is a complex multi-tissue disease, involving the whole joint, T2 mapping has the 
best potential for quantifying knee OA 6,25.
The results of the present study suggest that T2 relaxation times, obtained with in vivo 
T2 mapping, can potentially be used as non-invasive biomarker to detect early changes 
in meniscal tissue that indicate degeneration. Given the important role of the menisci in 
the long-term health of the knee joint, such biomarkers for meniscal tissue quality and 
degeneration are of great value. The detection of early meniscal tissue changes, indicating 
degeneration, would allow a better understanding of the etiology and development of knee 
OA. Furthermore, it would allow the identification of patients at early OA stages, before 
irreversible damage occurs. Also, it would improve the monitoring of disease progression and 
treatment response. The long-term goal would be to allow the detection and monitoring of 
early meniscal tissue changes that indicate an increased risk for knee OA, potentially enabling 
early treatment strategies for knee OA.
In conclusion, in vivo T2 mapping of the human meniscus provides accurate measurements 
of meniscal degeneration in patients with knee osteoarthritis. By quantifying subsurface 
meniscal changes, T2 mapping potentially provides a non-invasive imaging biomarker for 
meniscal degeneration.
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SUPPLEMENTArY MATEriAL 1: ASSESSMENT oF rADioGrAPHiC 
kNEE oA
The degree of radiographic knee osteoarthritis was graded according to the Kellgren and 
Lawrence (KL) classification system ranging from 0 (no OA) to 4 (end stage OA). The KL 
classification includes the assessment of joint space narrowing, osteophytes, subchondral 
sclerosis, and deformity of bone contour. Grading was performed by a musculoskeletal 
radiologist with 12 years of experience, using weight bearing anteroposterior radiographs. 
Radiographs and MR imaging scans were acquired on the same day.
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AbSTRACT
objective: To assess the discriminative power of a 5-minute quantitative double-echo 
steady-state (qDESS) sequence for simultaneous T2 measurements of cartilage and meniscus, 
and structural knee osteoarthritis (OA) assessment, in a clinical OA population, using radio-
graphic knee OA as reference standard.
Methods: 53 subjects were included, divided over three groups based on radiographic and 
clinical knee OA: 20 subjects with no OA (Kellgren-Lawrence Grade (KLG) 0), 18 with mild 
OA (KLG2) and 15 with moderate OA (KLG3). All patients underwent a 5-minute qDESS 
scan. We measured T2 relaxation times in four cartilage and four meniscus regions-of-
interest (ROIs) and performed structural OA evaluation with the MRI Osteoarthritis Knee 
Score (MOAKS) using qDESS with multiplanar reformatting. Between-group differences in 
T2 values and MOAKS were calculated using ANOVA. Correlations of the reference standard 
(i.e., radiographic knee OA) with T2 and MOAKS were assessed with correlation analyses for 
ordinal variables.
results: In cartilage, mean T2 values were 36.1 ± SD 4.3, 40.6 ± 5.9 and 47.1 ± 4.3 ms for 
no, mild, and moderate OA, respectively (P<0.001). In menisci, mean T2 values were 15 ± 
3.6, 17.5 ± 3.8 and 20.6 ± 4.7 ms for no, mild, and moderate OA, respectively (P<0.001). 
Statistically significant correlations were found between radiographic OA and T2 and be-
tween radiographic OA and MOAKS in all ROIs (P<0.05).
Conclusion: Quantitative T2 and structural assessment of cartilage and meniscus, using a 
single 5-minute qDESS scan, can distinguish between different grades of radiographic OA, 
demonstrating the potential of qDESS as an efficient tool for OA imaging.
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INTRODuCTION
The growing population suffering from knee osteoarthritis (OA) and the lack of early biomark-
ers and therapeutics prompt the need for efficient imaging methods 1. Magnetic resonance 
imaging (MRI) allows assessment of the whole knee joint, making it ideally suited for imaging 
in knee OA, which is a multi-tissue disease 2,3. Several potential MRI-based biomarkers have 
been proposed in this context 4. In particular, the role of quantitative MRI (qMRI) techniques 
is emerging. qMRI techniques, such as T2 mapping, have the ability to non-invasively de-
tect subtle changes in biochemical composition of tissues such as cartilage and menisci. 
Increased T2 relaxation times have been shown to be associated with cartilage and meniscus 
degeneration, potentially enabling early stage detection of knee OA and similar conditions 
5-8. T2 mapping does not require a contrast injection or special MRI imaging hardware and 
numerous techniques for post-processing of T2 images are available 5,7,9,10.
Besides quantitative MR imaging, structural evaluation of the knee is fundamental in 
the assessment of knee OA, given its multi-tissue nature 2,3. The semi-quantitative MRI 
Osteoarthritis Knee Score (MOAKS) 11 is a widely used and well-validated instrument for 
evaluating knee OA, and has been applied in large scale epidemiological OA studies such as 
the Osteoarthritis Initiative (OAI) 11-14.
T2 mapping and MOAKS are potential biomarkers to non-invasively assess joint health; 
however, acquiring them efficiently is a challenge. In general, multiple sequences are used in 
knee OA imaging, often resulting in time consuming MRI protocols that take 30-45 minutes 
or longer 6,15. In particular, in the context of large-scale clinical trials and repeated measure-
ments, MRI acquisition can create a significant burden for patients, hospitals, and research 
budgets. In the context of quantitative MRI, multiple sequences also bring up the need 
for registration between sequences. Hence, creating more streamlined MRI protocols and 
reducing acquisition time is of great interest.
In the present study, we evaluated a novel MRI technique to reduce scan time in the 
context of knee OA: the quantitative double-echo steady-state (qDESS) sequence. qDESS 
generates two echoes: one echo with T1/T2 weighting (resembling proton-density contrast), 
and one echo with T2 weighting. It has the potential to provide diagnostic images as well as 
quantitative measurements (i.e., T2 maps) of the knee in a single sequence with an acquisi-
tion time less than five minutes 16,17.
Proof-of-concept of qDESS for T2 mapping of cartilage and meniscus and structural knee 
assessment (using MOAKS) has been provided by Chaudhari et al. 16. Focusing on healthy 
subjects, they validated qDESS against routine methods for T2 measurements and MOAKS 
and reported high accuracy in most tissues. Also, a pilot study in 10 patients with knee OA, 
performed in the same work, provided promising qDESS-based T2 mapping and MOAKS 
outcomes, suggesting that accurate knee OA measurements are possible with qDESS 16. 
Building upon this work, we further assessed the discriminative power of quantitative and 
Chapter 4
60
structural qDESS-based biomarkers, in a larger OA cohort against radiography, widely ac-
cepted as the gold standard for knee OA imaging 18,19. We evaluated structural MOAKS 
scores and T2 measurements of the knee cartilage and meniscus in a clinical OA population. 
In contrast to the approach of Chaudhari and colleagues, which comprised a global assess-
ment of cartilage and menisci, in the present study we evaluated predefined subregions of 
cartilage and menisci. Regional assessment is relevant as knee OA is a focal disease with an 
heterogenous disease pattern 6,20,21.
The aim of the present study was to assess the discriminative power of a single 5-minute 
qDESS MRI sequence for simultaneous T2 measurements of cartilage and meniscus, and 
structural knee OA assessment, in a clinical osteoarthritis population, using radiographic 
knee OA as a reference standard.
METHODS
Study population
This study was performed with approval from our Institutional Review Board and in compli-
ance with Health Insurance Portability and Accountability Act (HIPAA) regulations. Written 
informed consent was obtained from all participants after receiving full explanation about the 
study. Consecutive patients who were referred by the Department of Orthopedic Surgery for 
knee MRI at Stanford Medical Center between December 2016 and July 2017 were screened 
for eligibility. The eligibility criteria for this study are shown in Table 1. Based on radiographic 
(Kellgren and Lawrence grade (KLG) 22) and clinical (American College of Rheumatology 
(ACR) criteria 23) degree of knee OA, three subject groups were selected: subjects with no 
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OA (KLG0 and ACR negative), subjects with mild OA (KLG2 and ACR positive), and subjects 
with moderate OA (KLG3 and ACR positive).
Scoring of radiographic knee oA
The assessment of radiographic knee OA was performed according to the KLG criteria 22, by 
a researcher with a medical degree and four years of experience in musculoskeletal imaging 
research (SE) who was blinded to any patient data. Standardized, weight-bearing AP radio-
graphs were used. A second reader, a musculoskeletal radiologist with 15 years of experience 
(EO) also performed the KL grading in a random selection of 20 subjects from the study 
population to assess interobserver reliability. To assess intra-observer reliability of the primary 
observer (SE) 20 randomly selected subjects from the study population were re-evaluated 14 
days after initial grading.
Mr imaging data acquisition
MR imaging was performed on one of two identical 3-Tesla MR scanners (Discovery MR750, 
GE Healthcare), using a 5-minute 3D sagittal qDESS scan with an 8-channel transmit-receive 
knee coil (InVivo). qDESS generates two echoes per repetition time: S+ (with T1/T2 contrast; 
echo time (TE) 5.7 ms; Figure 1a), and S- (with T2 weighting; TE 30.1 ms; Figure 1b) 16. 
The sagittal qDESS images were used to generate axial and coronal reformats (Figure 1d-f). 
Sequence parameters of qDESS are described in Table 2.
Structural analysis of knee oA (MoAkS scoring)
Structural, semi-quantitative assessment of cartilage and meniscus was performed using 
MOAKS 11 by the same researcher (SE). Both qDESS echoes with multiplanar reformatting 
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were used. Criteria for MOAKS grading for cartilage (MOAKScartilage) and meniscus (MOAKS-
meniscus), used in this study, are described in Supplementary Material 1 and 2, respectively. 
We performed no second reading because high intra- and inter-observer reproducibility for 
MOAKS scoring using qDESS with separated echoes, especially for cartilage and meniscus, 
was reported in a previous study 16.
Quantitative Mr analysis
The two echoes of qDESS were used to compute T2 relaxation time parameter maps, by invert-
ing the qDESS signal model 24. qDESS T2 measurements have shown to have high concordance 
with multi-echo spin echo T2 measurements 25 and limited sensitivity to T1 and signal to noise 
ratio variations in cartilage and meniscus 26. The first echo (S+) of sagittal qDESS was used 
for manual segmentation of cartilage and menisci for the calculation of T2 relaxation times 
(Figure 1c). Segmentation was performed on single slices, by the same researcher (SE) blinded 
for the patient’s clinical data. For femoral and tibial cartilage segmentation, the centermost 
Figure 1. representative example of (a) first and (b) second sagittal qDESS echo in 37-year-old female 
without OA, lateral compartment. In (a), femoral cartilage ROI is indicated by red dots, tibial cartilage 
ROI is indicated by blue dots, anterior meniscal horn is indicated by orange dots and posterior meniscal 
horn is indicated by green dots. (c) Corresponding T2 colormaps of femoral cartilage and the anterior 
and posterior horn of the lateral meniscus (color bar on the right shows the range of T2 values). Sagittal 
qDESS images are used to generate reformatted reconstructions in the (d, e) axial and (f) coronal plane. 
Abbreviations: Sag = sagittal; Ax = axial; Cor = coronal.
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slice through the medial and lateral femoral condyle (defined as the slice midway between 
the slice on which the femoral condyle was first visible and the slice on which the femoral 
condyle was last visible) was identified. Four cartilage regions of interest (ROIs) were defined 
per patient: medial and lateral femoral cartilage as well as medial and lateral tibial cartilage. 
The trochlear cartilage was not included in quantitative analysis because of the potential 
influence of the magic angle effect on T2 relaxation times in that specific region 27.
For meniscus segmentation, the sagittal slice depicting the maximum dimension of the 
anterior horn and posterior horn as individual triangles was used. Four meniscus ROIs were 
defined per patient: the anterior and posterior horn of the medial and lateral menisci. To 
avoid partial volume effects of joint fluid in case of a meniscal tear, the torn area was not 
included in segmentation. All segmentations and subsequent T2 analyses were performed 
using custom in-house software created in MATLAB (version R2011b; The Math-Works).
Statistical analysis
We assessed the intra- and interobserver reproducibility for KLG scoring by calculating 
weighted Cohen’s kappa’s. Tests for normality of baseline characteristics and outcomes were 
performed using Shapiro-Wilk tests. Between-group differences in overall (i.e., pooled across 
all ROIs) T2 values and MOAKS scores were evaluated using ANOVA (for parametric data) 
or Kruskal-Wallis tests (for non-parametric data). In case of statistically significant differ-
ences in mean age and/or sex among the three subject groups, a multivariate model with 
linear regression was used to assess the potential influence of these differences on T2 values 
and MOAKS scores. Associations between radiographic OA and T2 values and between 
radiographic OA and MOAKS were assessed in predefined cartilage and meniscus ROIs, and 
for overall scores using correlation analysis for ordinal variables (Spearman’s correlation). 
Differences were considered statistically significant at P < 0.05. All statistical analyses were 
performed using SPSS (version 24.0.0.0, 2018).
RESuLTS
Characteristics of study population
Out of the 196 potentially eligible patients, 53 subjects were included in this study: 20 
subjects without knee OA, 18 subjects with mild knee OA, and 15 subjects with moderate 
knee OA. A flowchart of the selection of the study population is presented in Figure 2. Char-
acteristics of study participants, stratified by degree of OA, are summarized in Table 3. There 
was a slight overall male predominance of 60%, yet no statistically significant differences in 
sex distribution were found across the three subject groups. The mean age of patients with 
mild and moderate OA was statistically significantly higher (P < 0.001) compared to subjects 
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with no OA. No statistically signifi cant association between age and T2 values or MOAKS 
scores was found (data not shown).
reproducibility of kLG scoring
Interobserver reproducibility for scoring the degree of radiographic knee OA according to 
KLG was good (weighted kappa: 0.78), while intra-observer reproducibility was excellent 
(weighted kappa: 0.85).
MR	imaging	of	the	knee	
between	Dec	16	–	July	17	
n	=	196	
Grading	of	radiographic	
knee	OA	
n	=	161	
Btudy	populaCon	
non-OA	subjects	
n	=	20	
Btudy	populaCon	
OA	subjects	
n	=	33	
No	anteroposterior	
weightbearing	radiograph	
available	of	index	knee	
n	=	35	
Excluded:	
-	KL0,	but	previous	surgery	or	
clinical	OA,	n	=	36	
-	KL1	or	KL4,	n	=	42	
-	KL2	or	KL3	but	did	not	fulﬁll	
ACR	criteria	for	AO,	n	=	21	
-	ACL	reconstrucCon	index	
knee,	n	=	9	
Figure 2. Flow-chart showing the selection process of the study population. In the rectangles on the 
right, the number and nature of exclusions is described. Abbreviations: MR = magnetic resonance; Dec 
= December; OA = osteoarthritis; KL = Kellgren and Lawrence grade; ACR = American College of Rheu-
matology; ACL = anterior cruciate ligament.
qDESS T2 and MoAkS measurements in cartilage
Overall qDESS cartilage (i.e., pooled across all ROIs) T2 values were 36.1 ± SD 4.3, 40.6 ± 5.9 
and 47.1 ± 4.3 ms for no, mild, and moderate OA, respectively. The delta value (difference) in 
T2 was 4.6 ms between no OA and mild OA and 6.5 ms between mild OA and moderate OA. 
Overall qDESS cartilage T2 values were similar to T2 values in previous literature (33.8-38.8, 
34.9-41.8 and 40.5-46.9 ms for no, mild, and moderate OA, respectively 7,16,28). Differences 
in qDESS T2 values were statistically signifi cant between the three subject groups (P < 0.01, 
Figure 3a).
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Figure 3. Discriminative power of quantitative and structural qDESS-based measurements in cartilage. 
Statistical signifi cantly differences in (a) cartilage T2 and (b) MOAKScartilage scores were found among 
subject groups. Data is shown as overall mean values (pooled across all ROIs); vertical bars represent 
standard deviation. Horizontal bars represent statistically signifi cance between two subject groups; ** 
= P < 0.01, *** = P < 0.001, **** = P < 0.0001. Abbreviations: ms = milliseconds; OA = osteoarthritis; 
ROI = region of interest.
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Likewise, overall MOAKScartilage scores were consistently higher with increasing stages of 
OA with statistically significant differences found between the three subject groups (P < 
0.001; Figure 3b). The delta value (difference) in MOAKScartilage was 4 between no OA and 
mild OA and 6.8 between mild OA and moderate OA. A representative example of qDESS 
MOAKScartilage findings in a subject with moderate OA, compared to a corresponding fat-
suppressed T2-weighted image, is provided in Figure 4. Osteophytes were not included in 
the analyses of the present study, but they were identified on qDESS images. Subchondral 
cysts and surrounding bone marrow lesions (BMLs) were not included in the analyses of this 
study but identified as well (see Figure 4). Overall qDESS T2 and MOAKS scores for cartilage, 
stratified by degree of OA, are summarized in Table 4.
Figure 4. Example of MOAKScartilage assessment in 71-year-old male with moderate OA on (a, b) qDESS 
images, compared to (c) corresponding fat-suppressed T2-weighted image (TE 54 ms; flip angle 142°; 
FOV 14 cm; matrix 384x192). Sagittal images of (a) first and (b) second qDESS echo show thinning of 
medial femoral cartilage (dotted arrow). Subchondral cysts and surrounding BML (dashed arrow) and 
osteophytes (triangles) were not included in the analysis of the present study, but they were identified on 
qDESS images. Note the underestimation of BML size on qDESS images compared to T2-weighted image. 
Abbreviations: OA = osteoarthritis; BML = bone marrow lesion.
qDESS T2 and MoAkS measurements in menisci
In menisci, overall (i.e., pooled across all ROIs) qDESS T2 values were 15 ± SD 3.6, 17.5 ± 3.8 
and 20.6 ± 4.7 ms for no, mild, and moderate OA, respectively. The delta value (difference) 
in T2 was 2.5 ms between no OA and mild OA and 3.1 ms between mild OA and moderate 
OA. Overall qDESS meniscus T2 values were similar to T2 values in previous studies (11.4-21.3, 
13.5-22.4 and 16.8-24.2 ms for no, mild, and moderate OA, respectively 7,16,29). Differences 
in qDESS T2 values were statistically significant between the three subject groups (P < 0.01; 
Figure 5a).
Differences in qDESS MOAKSmeniscus scores were statistically significant between the three 
subject groups (P < 0.001; Figure 5b), except for the difference in MOAKSmeniscus scores be-
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tween subjects with mild and moderate OA. The delta value (difference) in MOAKSmeniscus was 
2.2 between no OA and mild OA and 1.5 between mild OA and moderate OA. An example 
of qDESS MOAKSmeniscus assessment in a subject with mild OA, compared to a correspond-
ing proton density-weighted image, is provided in Figure S1. Overall qDESS T2 values and 
MOAKS scores for menisci, stratified by degree of OA, are summarized in Table 5.
Figure 5. Discriminative power of quantitative and structural qDESS-based measurements in menisci. 
Statistical significantly differences in (a) meniscus T2 and (b) MOAKSmeniscus scores were found among 
subject groups. Data is shown as overall mean values (pooled across all ROIs); vertical bars represent 
standard deviation. Horizontal bars represent statistically significance between two subject groups; ** 
= P < 0.01, *** = P < 0.001, **** = P < 0.0001. Abbreviations: ms = millisecond; OA = osteoarthritis; 
ROI = region of interest.
With regard to meniscus extrusion, the presence of meniscus extrusion was consistent 
with the degree of OA. We found a medial extrusion of 0.3 ± SD 0.1, 0.9 ± 0.3 and 1.1 ± 
0.3 in non-OA subjects, subjects with mild OA, and subjects with moderate OA, respectively. 
A lateral extrusion of 0.0 ± SD 0.0, 0.4 ± 0.2 and 0.7 ± 0.3 was found in non-OA subjects, 
subjects with mild OA, and subjects with moderate OA, respectively. Statistically significant 
differences in medial and lateral extrusion grade were found among the three subject groups 
(P = 0.04 and P = 0.03 for medial and lateral extrusion, respectively).
qDESS T2 and MoAkS in cartilage and meniscal rois
qDESS T2 values and MOAKS scores for each cartilage and meniscus ROI, stratified by degree 
of OA, are summarized in Table 4 and Table 5, respectively. In all cartilage and meniscus ROIs, 
statistically significant correlations were found between qDESS T2 values and radiographic 
OA and between MOAKS scores and radiographic OA. The strongest correlation (r = 0.71) 
between MRI findings and radiographic OA was found in the medial femoral cartilage, the 
weakest correlation (r = 0.29) was found in the anterior horn of the medial meniscus.
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DISCuSSION
In the present study, we demonstrated that quantitative and structural measurements in 
cartilage and meniscus, obtained with a single 5-minute qDESS sequence, can differentiate 
between OA stages. T2 values in cartilage and menisci were similar to T2 values reported in 
previous studies 5-8.
The disease distribution of OA within the knee joint is often compartmental, with high 
variability regarding compartmental involvement 6,20,21. Therefore, we assessed the validity of 
qDESS-based biomarkers in various cartilage and meniscus ROIs. The discriminative power to 
distinguish degree of OA was the greatest in the medial femoral cartilage, and the least in the 
anterior horn of the medial meniscus. These findings were most likely caused by the uneven 
distribution of OA features; the anterior horn of the medial meniscus showed relatively low 
T2 values and MOAKS scores in subjects with mild or moderate OA while the medial femoral 
cartilage showed relatively high T2 values and MOAKS scores in those subjects. Despite the 
differences in discriminative power, T2 values and MOAKS outcomes in all ROIs were found 
to be statistical significantly correlated with radiographic knee OA.
The qDESS sequence in the present study was optimized to simultaneously generate high 
resolution images and quantitative measurements, by combining high spatial resolution with 
high SNR, in one single, rapid scan. While twice as fast, the resolution and voxel volume of 
this qDESS sequence (0.18μL) was over 10x better than the resolution of established quan-
titative T2 sequences 7,30. In a previous study, qDESS has shown high T2 accuracy compared 
to multi-echo spin echo sequences, as well as high accuracy for MOAKS measurements 
Figure S1. Example of MOAKSmeniscus findings in 47-year-old male with mild OA, on sagittal images of 
(a) first and (b) second qDESS echo, compared to (c) corresponding proton density-weighted image (TE 
35 ms; flip angle 142°; FOV 14 cm; matrix 384x224), showing a complex tear (solid arrow) in the pos-
terior horn of the medial meniscus. MOAKSmeniscus scoring in the present study included meniscus signal, 
tears, and (partial) maceration. The second qDESS echo especially was useful in identifying meniscus 
pathology. Abbreviations: OA = osteoarthritis; PD = proton density.
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compared to conventional spin echo based sequences, with high intra- and inter-observer 
reproducibility 16,25. qDESS has been thought to underestimate the size of bone marrow 
lesions (BMLs), which seems to be the case in our study as well (see Figure 4, not studied), 
likely due to T2* susceptibility effects 15. A separation of the two qDESS echoes may enhance 
accuracy of BML detection compared to previous qDESS studies 31. Although outside the 
scope of this study, further work is needed to test and optimize BML detection with qDESS.
Building upon the work of Chaudhari et al. 16, the present study assesses the discriminative 
power of a 5-minute qDESS sequence to obtain T2 values and MOAKS in a clinical knee OA 
population. We validated T2 measurements and MOAKS against radiographic OA, which 
remains the gold imaging standard for diagnosing and monitoring knee OA 18,19. In OA 
research, KLG2 is considered the cut-off point for the presence of radiographic knee OA 
4,18,19,32. Although potentially a relevant group in the context of early OA imaging, we did 
not include patients with KLG1, indicating doubtful radiographic OA. The reproducibility 
of scoring KLG1 (i.e., doubtful narrowing of joint space and possible osteophytic lipping) is 
relatively poor, most likely due to differences in the interpretation of radiographic findings, 
especially concerning osteophytic lipping 18. Also, patients with severe radiographic OA (i.e. 
KLG4) were not included in the present study, as bony deformity and bone-to-bone contact 
precludes accurate segmentation of cartilage.
OA is among the top ten burdensome diseases, with the knee being the most affected joint 
1. In the light of increased numbers associated MR imaging studies 2,33, reducing MR imaging 
acquisition time is highly relevant. Reducing scan time saves costs and increases patient 
comfort and may reduce motion artifacts in longer acquisitions 16. Because qDESS rapidly 
provides rich structural and quantitative information, there is a great promise for using this 
technique in large clinical OA studies. Recent advances in deep learning and simultaneously 
imaging both knees with qDESS may further reduce scan time, without loss of image quality 
or quantitative accuracy 34-36.
This study has some limitations that must be acknowledged. First, segmentation of quan-
titative analysis and MOAKS scoring was performed by a single, experienced researcher. 
As evidence of high intra- and inter-observer reproducibility for cartilage and meniscus 
segmentation and MOAKS assessment with qDESS images has been reported previously 16, 
analyses performed by a single researcher was considered sufficient. Second, our validation 
study was cross-sectional. The lack of a longitudinal aspect may limit interpretation regard-
ing the potential use of qDESS in clinical trials. Therefore, future studies on the sensitivity 
of qDESS-based biomarkers for longitudinal changes in the knee are required. Third, KLG 
was used as reference standard, which is considered the gold standard for imaging-based 
knee OA classification 4. Radiographically detected joint space narrowing (JSN) is currently 
the only structural endpoint accepted by the European and US regulatory bodies (European 
Medicines Agency and FDA) to assess knee OA progression 37 and is commonly used in qMRI 
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validation studies 6,7. We opted for this method because we aimed to explicitly use qDESS in 
a clinically relevant matter. However, an important drawback of the KLG method is the low 
reproducibility of JSN measures reported in literature, in particular in longitudinal assessment 
of knee OA 4,38. Given the cross-sectional design of our study without longitudinal measures, 
challenges concerning longitudinal KLG measures are unlikely. To optimize reproducibility, we 
used standardized radiographs (weight-bearing AP). To assess reproducibility, both inter- and 
intra-observer reproducibility of KLG were carefully evaluated in the present study (weighted 
kappa of 0.78 and 0.85 for inter- and intra-observer reproducibility respectively). Finally, 
although osteophytes and BMLs are important OA features, they were not studied. The 
primary objective of this study was to assess the validity of qDESS for cartilage and menisci 
in OA subjects. We focused on those tissues as they have conclusively been shown to be 
strong indicators for OA and because of their possibilities in both quantitative (T2) and semi-
quantitative (MOAKS) 4,7,8,11,39. To assess the external validity of our study results, further 
studies evaluating other relevant OA features will be essential, in particular regarding BML 
detection. In addition, future validation studies on qDESS T2 values in OA patients against 
histological degree of degeneration (the gold standard for tissue changes) are desirable.
In conclusion, quantitative T2 and structural assessment of cartilage and meniscus with 
a single 5-minute qDESS scan can distinguish between different grades of OA and show 
significant correlations with the reference standard. These results demonstrate the potential 
of qDESS as an efficient and accurate imaging tool for OA research.
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SUPPLEMENTArY MATEriAL 1: MoAkS GrADiNG For CArTiLAGE
For structural, semi-quantitative assessment of cartilage in the present study, cartilage sub-
scores (MOAKScartilage), directly derived from the MOAKS total scores, were used (described in 
Table S1). MOAKScartilage includes the size of cartilage lesions and the percentage of cartilage 
lesions being full thickness [1].
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SUPPLEMENTArY MATEriAL 2: MoAkS GrADiNG For MENiSCUS
For structural, semi-quantitative assessment of the meniscus in the present study, meniscus 
subscores (MOAKSmeniscus) based on MOAKS total scores were used, including meniscus sig-
nal, tears, and (partial) maceration (described in Table S2). The rationale behind MOAKSmeniscus 
criteria and the hierarchy in MOAKSmeniscus scoring used in the present study was based on the 
clinical important effects these meniscus findings have as described in literature [2; 3]
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AbSTRACT
objective: Meniscal damage is, despite its major role in knee osteoarthritis (OA), often 
neglected in OA animal models. We evaluated structural meniscal degeneration during the 
course of OA in the murine collagenase-induced OA (CIOA) model.
Methods: OA was induced in the knee joints of 33 male C57BL/6 mice by an intra-articular 
injection of 10U collagenase. The mice were sacrificed after 1, 3, 7, 14, 28, and 56 days, and 
the knees were harvested and processed for histological analysis. As control, 6 knees were 
obtained from 16-week-old mice in which no OA was induced. Meniscal damage, meniscal 
extrusion, and articular cartilage damage were evaluated on thionin-stained sections. Asso-
ciations between parameters of interest were evaluated with Spearman rho correlation tests.
results: When compared to non-OA knees, meniscal extrusion was visible from day one 
onwards and meniscal degeneration had a tendency to increase over time. The meniscus 
damage appeared around the same time as articular cartilage damage (day 14-28) and was 
statistically significantly more pronounced anterior than posterior, and no differences were 
seen between medial and lateral menisci. Meniscus and articular cartilage damage were 
moderately associated in the CIOA knees (ρ=0.57; 95%CI [0.23-0.78]).
Conclusions: Our findings suggest that the CIOA model is a valuable model to study the 
role of meniscal damage during OA progression and can support the development of future 
preventative treatment strategies.
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INTRODuCTION
Meniscal degradation is, in spite of its critical role in knee osteoarthritis (OA), often neglected 
in OA animal models. Meniscal damage is one of the strongest identified risk factors for the 
development and progression of knee OA 1-7. In addition, indications that meniscal extru-
sion, that is, radial displacement of the meniscus outside of the joint cartilage margin, is 
independently related to knee OA development have been reported previously 8-10. Menis-
cal integrity is, therefore, an important factor in the long-term health of the knee joint 11. 
Paradoxically, little is known of the exact relationship between meniscal degradation and 
cartilage degeneration in the development of knee OA.
Murine models for OA are frequently used to study the etiopathogenesis of knee OA in 
fundamental and translational studies, due to the possibility to study the disease on a patho-
physiological level, or to study the effects of an experimental therapy 12. Despite its major 
role in knee OA, the menisci are grossly neglected in the diagnosis of murine knee OA. A 
frequently used enzyme-based model is the collagenase-induced OA (CIOA) model 13, where 
highly purified collagenase is injected intra-articularily and affects joint ligaments, resulting in 
joint instability 13,14. Another often used murine OA model is the surgical destabilization of the 
medial meniscus (DMM) 15, a model in which the ligament that attaches the medial meniscus 
to the tibia is transected, resulting in an instable and displaced meniscus. Recently, a systemic 
evaluation method for degeneration of the meniscus in experimental OA was established by 
Kwok et al. 16. In the study, the authors reported insights on the structural changes of the 
menisci during ageing and OA and have shown that in the DMM model, meniscal damage 
and articular cartilage damage develop synchronously from day 14 onwards. No studies have 
been conducted on the elapsed meniscal degeneration in the CIOA model. Therefore, the 
aim of this study was to evaluate meniscal damage during the course of experimental knee 
OA in the CIOA mouse model, immediately after OA onset.
METHODS
induction of experimental oA
The animal experiments were carried out in correspondence with the ARRIVE Guidelines for 
Reporting Animal Research 17, and with the approval of the Animal Ethical Committee of 
the Erasmus Medical Center (approval no. EMC 3246, 114-14-01). OA was induced using 
the CIOA model in the right knees of 33 male C57BL/6J01aHsd mice (28.4 ± 3.1 g; 12 to 
14 weeks old; Envigo, Cambridgeshire, UK) as described previously 13. Briefly, the mice were 
randomly taken from their cages and were anesthetized with 3% isoflurane/0.8 L O2/min 
(Pharmachemie BV, Haarlem, the Netherlands). The knees were sprayed with 70% ethanol 
(BoomLab, Meppel, the Netherlands). A dermal incision was then made at the height of the 
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patellar tendon and a 6 µL solution containing 10U collagenase from clostridium histolyticum 
(Sigma-Aldrich, St. Louise, USA) in saline (Sigma-Aldrich) was injected intra-articularily in 
the right knees. All animals were housed at the Experimental Animal Facility of the Erasmus 
Medical Center in standard caging under a standard 12-hour light/dark cycle in groups of 3-9 
including cage enrichment and received acid tapwater and standard chow ad libitum. The 
mice were sacrificed by cervical dislocation 1, 3, 7, 14, 28, or 56 days after CIOA induction 
and the knees were processed for histological analysis. The final number of knees used for 
analysis was: 8 mice at day 1, 7 mice at day 3, 3 mice at day 7, 9 mice at day 14, 3 mice 
at day 28, and 3 mice at day 56. As controls, 6 naïve knees were obtained from three 16 
week-old mice in which no OA was induced.
Histological scoring of structural meniscal damage, meniscal extrusion, 
and articular cartilage damage
The knees were harvested and fixed in 4% formaldehyde (BoomLab) for 10 days and decalci-
fied for 10 days in 10% ethylenediaminetetraacetic acid (Sigma-Aldrich). The tissue was then 
dehydrated in an ascending series of alcohol, embedded in paraffin, and sectioned serially at 
6 µm in the coronal plane. The sections were stained with thionin (Sigma-Aldrich) and images 
were taken with a NanoZoomer 2.0-HT slide scanner (Hamamatsu, Hamamatsu City, Japan).
Meniscal damage was assessed according to the validated method described by Kwok et 
al.16 in which the menisci were evaluated based on surface integrity, cellularity and staining 
intensity, with a maximum possible score of 21. The scoring was separately conducted by 
two researchers experienced in histological grading (LU and SME) in a complete observation-
blinded manner, meaning unaware of time-point, case-control status, and each other’s 
scores. The inter-observer reliability of the meniscus damage scoring was excellent, with an 
ICC of 0.84 (95%CI [0.63 – 0.93]).
Meniscal extrusion of the medial and lateral meniscal body was assessed on the same sec-
tions as used for histological evaluation. Extrusion is where the meniscus is partially or totally 
displaced from the tibial cartilage surface 9. This feature was scored from 0 to 4 where: 0=no 
extrusion, 1 = mild extrusion, 2 = moderate extrusion, 3 = severe extrusion, 4 = complete 
displacement of the meniscus. The assessment for meniscal extrusion was performed by LU 
and its evaluation extensively discussed with the co-authors (SME, DM, GJVMvO and YMBJ).
Structural articular cartilage damage was assessed in all four quadrants of the knee in 
four sections according to a modified grading and staging score for murine cartilage that 
was initially based on the score described by Pritzker et al. 18. The score was determined by 
multiplying a grade (0-6) and a stage (0-4) and the maximum score of four sections of each 
quadrant was evaluated, accounting for a total of 16 scores throughout the entire knee joint. 
The score of the four quadrants was then summed to determine the total articular cartilage 
damage score in the knee resulting in a maximal possible score of 96. The ICC of the cartilage 
score was 0.81 (95%CI [0.42 – 0.84]).
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Statistical analysis
Calculations for the histological scores were conducted with MS Excel 2016 (Microsoft, 
Redmond, USA) and IBM SPSS 23.0 (IBM, New York, USA) was used for statistical evaluation. 
Mann-Whitney U tests were conducted to evaluate statistically significant differences of the 
non-parametric values of interests (i.e., meniscus damage and meniscal extrusion) between 
independent groups (i.e., per time point compared to the non-OA knees). The association 
between meniscus damage and articular cartilage damage was evaluated with a Spearman 
rho correlation test followed by Bonferroni correction and bootstrap-based calculations to 
calculate the 95% confidence interval (95%CI). P values of < 0.05 were considered statisti-
cally significant.
RESuLTS
Meniscus extrusion and damage during the course of experimental oA
Meniscal extrusion was visible (Figure 1-A) and statistically significantly more present than 
in the non-OA knees from day 1 onwards (Figure 1-B). No differences in extrusion were 
seen between the medial and lateral sides (data not shown). Meniscal degeneration was 
evaluated for surface structure, cellularity, and matrix staining and all three parameters had 
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Figure 1. Meniscus extrusion during the 
course of oA development. A) Representa-
tive images of five degrees of meniscal extru-
sion on thionin-stained sections. B) Meniscal 
extrusion score after induction of OA where 0 
=no extrusion, 1 =mild extrusion, 2 = moder-
ate extrusion, 3 = severe extrusion, 4 = com-
plete displacement of the meniscus. Each sym-
bol represents a data point of the individual 
knees and the horizontal lines represent the 
median value. *: P < 0.05. Abbreviations: OA = 
osteoarthritis; F = femural condyle; T = tibia; M 
= meniscus; M* = displaced meniscus; CIOA = 
collagenase induced osteoarthritis.
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Figure 2: Meniscus damage during the course of collagenase-induced oA in mice knees. A) 
Subdomains of meniscus damage score; cellularity, staining intensity, surface integrity. Each symbol rep-
resents a data point of the individual knees and the horizontal lines represent the median value. B) Plot 
showing that meniscus damage was mild up until 56 days after induction of OA. Each symbol represents 
a data point of the individual knees and the horizontal lines represent the median value. C) Spearman 
correlation between meniscus damage and articular cartilage damage in the CIOA knees. Differences in 
meniscus damage between (D) anterior and posterior, and (E) medial and lateral sides of the knees. The 
data is show as median with whiskers from minimum to maximum. *: P < 0.05; **: P < 0.01. Abbrevia-
tions: OA = osteoarthritis; CIOA = collagenase induced osteoarthritis.
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a tendency to increase over time compared to the non-OA knees from day 14 on, albeit not 
significantly (Figure 2-A). When the three parameters were combined, the total meniscus 
damage score in the CIOA knees tended to be higher at day 14 and 28 than in the non-OA 
knees (Figure 2-B). Meniscus and articular cartilage damage were moderately associated 
(ρ=0.57; 95%CI [0.23-0.78]; Figure 2-C) in the CIOA knees and the meniscus damage ap-
peared around the same time as articular cartilage damage (day 14-28; data not shown). As 
for the locations within the knees where the damage appeared, meniscus degeneration was 
more pronounced anterior than posterior in both the CIOA knees and non-OA knees (Figure 
2--D). No differences were seen between medial and lateral menisci (Figure 2E).
DISCuSSION
We assessed meniscal extrusion and degeneration during the course of OA in the murine 
CIOA model. The results of this study suggest that structural meniscal degeneration appears 
simultaneously with articular cartilage degeneration and that they are correlated, indicating 
that meniscal degeneration is an important parameter when assessing OA in the CIOA model. 
Despite the fact that the major role of the meniscus in the development of knee OA is well 
established 1,3-10, this is the first study evaluating meniscal damage in the murine CIOA model. 
In another study by Kwok et al., meniscal degeneration was assessed in the DMM model 16. 
As meniscal damage was evaluated only 14 days after OA induction, relevant information 
during early OA onset may have been missed. In our study, we have found that meniscal 
damage and cartilage damage appear simultaneously, which is in concordance with findings 
by Kwok and colleagues 16. We have additionally shown that meniscal extrusion was higher 
after one day in the collagenase-injected knees than in the non-OA knees. These findings 
suggest that the injected collagenase might have also affected the meniscal ligaments that, 
due to mechanical loading might have become insufficient, leading to meniscus extrusion. 
The degenerating processes of joint tissues in early stage knee OA is not limited to articular 
surface cartilage, but also affects meniscus integrity, as suggested in previous literature 6. Our 
findings may lead to a deeper understanding of the cascade of the development of knee OA 
and the complex interplay and role of the meniscus in this context. Ultimately, these insights 
may contribute to the development of effective therapeutic options for early OA.
Although OA animal models are useful tools to study diseases, they have limitations as 
well. The CIOA model that is used in this study, can be categorized as a classic model for im-
mediate joint instability and critical structural damage 14,19,20. Even though the CIOA mouse 
is a widely used model for knee OA, as it presents with OA characteristics such as structural 
cartilage damage, osteophytes, synovitis and joint instability, there are obvious important 
differences between murine and human menisci. The meniscus morphology in mice differs 
from human menisci; mice menisci are thicker and less symmetrical in the proximal-distal 
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direction because of the posture of the animal, since a mouse knee is in a more flexed 
position than a human knee. Moreover, there are differences in histological staining profiles. 
The staining intensity increases with age and degree of degeneration in human menisci, 
whereas in mice this is reversed as the staining intensity appears less intense and is disrupted 
in older subjects 16,21. The reason for these differences and the meaning for the process of 
OA development is not clear and must be taken in consideration when assessing meniscal 
damage in a murine OA model.
CONCLuSION
To conclude, several studies have shown a correlation between extrusion of the meniscal 
body and knee OA 8,9 and meniscal extrusion is known to be independently related to car-
tilage loss 8-10,22. The generally accepted hypothesis is that an extruded meniscus modifies 
the load distribution and weight-bearing abilities within the knee joint, eventually resulting 
in the development of knee OA 8,22. Our study shows that meniscal extrusion appears early 
in the CIOA mouse model, and that meniscal damage and articular cartilage damage occur 
simultaneously. This highlights the CIOA model as a valuable model to study the role of 
meniscal damage during OA progression and the development of future preventative treat-
ment strategies.
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AbSTRACT
objective: In order to make a more evidence-based selection of patients who would benefit 
the most from arthroscopic partial meniscectomy (APM), knowledge of prognostic factors is 
essential. We conducted a systematic review of predictors for the clinical outcome following 
APM.
Methods:
Design: Systematic review
Data-sources:Medline, Embase, Cochrane Central Register, Web-of-science, SPORTDiscus,
Pubmed Publisher, Google Scholar
Inclusion criteria: report an association between factor(s) and clinical outcome; validated 
questionnaire; follow-up >1 year
Exclusion criteria: <20 subjects; ACL-deficient patients; discoid menisci; meniscus repair, 
-transplantation or -implants; total- or open meniscectomy
Data-extraction and analysis: Two reviewers extracted the data, assessed the risk of bias and 
performed a bestevidence synthesis
results: Finally, 32 studies met the inclusion criteria. Moderate evidence was found, that the 
presence of radiological knee-osteoarthritis at baseline and longer duration of symptoms (>1 
year) are associated with worse clinical outcome following APM. In addition, resecting more 
than 50% of meniscal tissue and leaving a non-intact meniscal rim after meniscectomy are 
intra-articular predictive factors for worse clinical outcome. Moderate evidence was found 
that sex, onset (acute or chronic), tear type or pre-operative sport level are no predictors for 
clinical outcome. Conflicting evidence was found for the prognostic value of age, periopera-
tive chondral damage, BMI and leg-alignment.
Conclusion: Long duration of symptoms (>1 year), radiological knee-osteoarthritis and 
resecting >50% of meniscus are associated with a worse clinical outcome following APM. 
These prognostic factors should be considered in clinical decision making for patients with 
meniscal tears.
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INTRODuCTION
A meniscal tear is a very common injury, with an incidence of patients visiting an orthopedic 
trauma department of 24/100.000 per year 1. The main symptoms are pain, swelling and 
dysfunction of the knee. A meniscal tear can be the result of a traumatic event or due 
to degeneration. Both non-operative and operative treatment options are available. Non-
operative treatment mainly involves exercise therapy and pain medication, whereas operative 
treatment of meniscal tears involves either arthroscopic partial meniscectomy (APM) or, in 
some cases, repair of the torn meniscus if feasible. For many years, APM has been considered 
the gold standard for torn menisci, for both traumatic and degenerative tears 2,3. Yearly, over 
700.000 APMs are performed in the U.S. 4.
Although it is still one of the most common surgical procedures in many Western countries 
5, several recently published high-quality RCTs challenge the indications of APM 4,6-9. These 
trials, summarized in a recent systematic review 10, consistently show no benefit of APM 
compared to physical therapy or sham surgery in patients with degenerative meniscal tears. 
Furthermore, there is a growing concern that patients who have undergone APM are at 
increased risk of developing knee osteoarthritis (OA) 2,11.
Taking the results of the earlier mentioned RCTs and the concern about knee OA into 
account, a more evidence-based approach in patient selection for APM is needed. Instead of 
considering APM the standard of care, clinicians need to carefully select subgroup of patients 
with meniscal pathology who would likely benefit from APM. If one can predict the chance 
of success following APM based on patient characteristics, a more evidence-based patient 
selection can be made. In order to predict this chance of success, knowledge of prognostic 
factors is essential.
To the best of our knowledge, no systematic review of prognostic factors for the clini-
cal outcome following APM has been conducted. We systematically reviewed all available 
literature, to determine the association between certain preoperative and operative variables 
and clinical outcome following APM. The purpose of this study was to identify prognostic 
factors for the clinical, patient-reported outcome of APM in patients with a meniscal tear.
METHODS
The reporting in this systematic review was conducted according to the Preferred Reporting 
Items for Systematic Review and Meta-analysis Protocols (PRISMA) statement 12. This study 
was registered in the International Prospective Register for Systematic Reviews (Prospero) of 
the National Institute for Health Research (NHS), no. 42016048592.
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Search strategy
A health science librarian of our institution with extensive experience in the conduct of 
literature searching for systematic reviews assisted in designing and performing the search. 
We searched in Medline, Embase, Cochrane Central Register, Web of Science, SPORTDiscus, 
PubMed Publisher, and Google Scholar for relevant articles (date of search: September 16th, 
2016). The following main keywords were used: knee, meniscus, meniscal tear, treatment, 
and meniscectomy (see Supplementary material 1 for complete search). The articles types 
included in the search were randomized controlled trials and prospective or retrospective 
cohort studies. There was no date of publication restriction in the search.
Study selection
The inclusion criteria for the present study were: 1) all subjects had to have a meniscal tear, 
confirmed by MRI (Magnetic Resonance Imaging)/arthroscopy/X-ray with contrast, treated 
with APM; 2) subjects had to be over 18 years of age; 3) the study had to describe a cor-
relation/association between certain prognostic factor(s) and clinical outcome of APM; 4) a 
validated patient reported outcome measure had to be used; 5) there had to be a follow-up 
of at least 12 months; and 6) the article had to be written in English, German, Dutch, French, 
Spanish, or Swedish. We choose these languages because members of the project group 
were able to read these.
We excluded studies which; 1) had less than 20 subjects; 2) included patients with ACL-
deficiency or with previous ACL-reconstruction; 3) included patients with discoid menisci; 
4) included patients undergoing meniscal repair; 5) included meniscus transplantation or 
meniscus implants; 6) included patients undergoing total meniscectomy; 7) included patients 
undergoing open meniscectomy; and 8) included additional surgical interventions carried out 
at arthroscopy.
Two reviewers independently screened all titles and abstracts for eligibility. Disagreements 
were discussed and resolved by consensus. A third reviewer was asked in case of unsolved 
disagreement. Duplicate studies were manually removed. Furthermore, reference lists of all 
selected studies were searched to identify potential missed articles.
risk of bias
To assess the potential risk of bias, two reviewers independently assessed each study using 
the Cochrane Collaboration’s tool for assessing risk of bias of prognostic studies 13,14. This 
scoring list involves eight questions; two questions concerning selection bias, three questions 
concerning information bias, and two questions concerning confounding. A low risk of bias 
was defined as 1) ‘’yes’’ to at least 70% of the questions (6 out of 8 questions) and 2) at least 
one time ‘’yes’’ in each risk of bias category (selection bias, information bias, confounding). 
A moderate risk of bias was defined as 1) ‘’yes’’ to at least 60% of the questions (5 out of 8 
questions) and 2) at least one time ‘’yes’’ in two of the risk of bias categories. All other cases 
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were considered as high risk of bias. The two reviewers discussed their findings and asked a 
third reviewer for consensus, if necessary.
Data extraction
Data regarding study design, level of evidence, number of patients, population character-
istics, arthroscopic findings, outcome measurements, results, and associated prognostic 
factors were extracted by one reviewer, using a standardized form.
Best evidence synthesis
The clinical and methodological homogeneity of the included studies was checked to evalu-
ate whether a meta-analysis would be appropriate. If not, a Best Evidence Synthesis was 
performed, using the algorithm developed by van Tulder et al. 15-17. By summarizing findings 
while taking the weight of the evidence into account in a standardized way, a Best Evidence 
Synthesis provides conclusions based on the best available evidence. The following ranking 
of levels of evidence was used: (1) Strong evidence is provided by two or more studies with 
low risk of bias and by generally consistent findings in all studies (≥75% of the studies 
reported consistent findings). (2) Moderate evidence is provided by one low risk of bias study 
and two or more moderate/high risk of bias studies or by two or more moderate/high risk of 
bias studies and by generally consistent findings in all studies (≥75%). (3) Limited evidence is 
provided by one or more moderate/high risk of bias studies or one low risk of bias study and 
by generally consistent findings (≥75%). (4) Conflicting evidence is provided by conflicting 
findings (<75% of the studies reported consistent findings). (5) No evidence is provided 
when no studies could be found. Besides overall analysis, subgroup analysis was performed 
regarding age (under- and above 45 years old).
RESuLTS
Search strategy
We identified 5,150 potentially relevant articles: 5,146 by electronic search and 4 by reference 
tracking. After screening on title and abstract, 159 studies were considered to be potential 
eligible (See Figure 1). Full text of these studies was assessed, and 32 studies met our inclu-
sion criteria and were included (See Table 1 for study characteristics and main results).
Characteristics of included studies
We included one randomized controlled trial 6, four prospective follow-up studies 18-21, and 
27 retrospective studies. Overall, the included studies had allocated 4,250 patients (range 26 
22 – 1090 23). The follow-up ranged from 1 6,19,23,24 to13 25,26 year. The mean age of patients 
of the included studies ranged from 19 26 to 60 27 years. Most articles included patients 
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with all types of meniscal tears, however two studies 28,29 only included radial tears, two 
studies 30,31 only horizontal tears, one study 32 only included root-tears, one study 33 only 
complex tears, and one study 34 only bucket-handle tears. Five studies excluded patients with 
a certain degree of chondral damage. Furthermore, 13 studies excluded patients with knee 
OA (mostly based on radiographs).
risk of bias of included studies
For two 6,35 of the 32 included studies we found a low risk of bias. For the remaining studies, 
a moderate to high risk of bias was found. A risk of selection bias was found in 77% of the 
included studies, a risk of confounding in 94% and a risk of information bias in none of the 
studies. The agreement between reviewers in the risk of bias assessment was 98%.
Figure 1. Flow-chart of screening and selection of studies. All steps were conducted according to 
the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA) statement.
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Heterogeneity
A significant amount of variety was found between included studies regarding study-
population, the definition of subgroups, and outcome measures. Furthermore, clinical 
outcomes of individual subgroups were often inadequately described or lacking completely. 
Taking the considerable heterogeneity and lacking subgroup-outcomes into account, pooling 
data and conducting a meta-analysis was not appropriate. Hence, qualitative analyses were 
performed, according to the Best Evidence Synthesis principle.
Prognostic factors
In total, 13 different prognostic factors were identified and shown to be associated with 
clinical outcome following APM. Table 2 shows an overview of prognostic factors, which are 
described in at least two studies.
1) MODERATE EvIDENCE
Prognostic factors:
Duration of symptoms
Two studies 36,37 evaluated the duration of symptoms in the context of clinical outcome. In 
one study 36 acute (symptoms existing less than 12 months) and chronic (symptoms existing 
more than 12 months) lesions are distinguished, one study 37 defined a duration of three 
months or less as ‘’short’’, and longer than three months as ‘’long’’’. Both studies concluded 
that a shorter duration of symptoms is statistically significantly associated with better patient 
reported outcome measures.
Radiological knee OA at baseline
Two studies 38,39 described the presence of radiological knee OA and its association with 
clinical outcome of APM. In one study 39, patients with no sign of knee OA (Kellgren and 
Lawrence 40 grade 0) and patients with mild to moderate knee OA (Kellgren and Lawrence 
grade 1-2) were included. One study 38, also included patients with severe knee OA (Fairbank 
41 grade > 2). Both studies reported a statistically significant smaller improvement of Lysholm 
knee scores in patients with radiological knee OA at baseline.
Amount of resected meniscal tissue
Six studies assessed the relationship between the amount of resected tissue during APM 
and clinical outcome. Five out of six studies reported a positive association between the 
amount of resected meniscal tissue and decreased patient reported outcome measures. In 
two studies 26,42, a ‘’subtotal’’ procedure (more than 50% resected, leaving a small rim of 
meniscal tissue) was found to result in worse clinical outcome than a ‘’partial’’ procedure (less 
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than 50% of meniscal tissue resected). Other studies described the absence of the meniscal 
rim 43 or a preserved meniscal width of less than 3 mm 44 as a predictor for worse clinical 
outcome. In one study 45, the method for measuring the influence of this factor on clinical 
outcome was not further described. One study 46, which investigated the influence of the 
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percentage of removed tissue in 31 knees with lateral meniscal tears, found no association 
with post-operative Lysholm scores.
Not prognostic factors:
Sex
The influence of sex on outcome after APM was assessed in ten articles. Eight of them 
reported no statistically significant association between sex and outcome. Two studies 19,21 
reported a worse outcome for women.
Traumatic versus degenerative tear
The influence of onset, i.e. traumatic versus degenerative, on outcome after APM was as-
sessed in eight articles and seemed not to be a predictor for clinical outcome. Two studies 27,47 
reported a worse outcome for degenerative tears, based on arthroscopic findings. However, 
six studies reported no statistically significant correlation.
Pre-operative sport level
In four studies preoperative sport level was assessed. Two studies 42,43 distinguished a recre-
ational and competitive sport level, one study 19 measured the hours of exercise per week 
and one study 48 did not further specify study groups. None of the articles found a correlation 
between sport level and outcome of APM.
Type of meniscal tear
In nine studies the association between the type of meniscal tear and clinical outcome 
was assessed. Eight of them found no association, whereas one study 36 reported a worse 
outcome for complex and for degenerative tears. None of the studies described a classifica-
tion system used for the type of meniscal tears. Furthermore, a large variety among studies 
was found regarding the definition of subgroups (types of meniscal tears). The amount of 
subgroups ranged from two 36,48 to five 23.
2) LIMITED EvIDENCE
An association between the location of the tear (medial versus lateral meniscus) and clinical 
outcome of APM was only described in one of our included studies 43; in this study no statisti-
cally significant difference was found between medial and lateral APMs. Regarding the side 
of knee 23, the location of chondral damage 49 and perioperative synovial inflammation 20, no 
correlation with clinical outcome was found as well. Furthermore, one of the included studies 
19 assessed the predictive value of self-reported fitness at baseline and prior knee surgery and 
found a worse Lysholm score one year after APM for women with lower self-reported fitness. 
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For men, no influence was found of self-reported fitness on clinical outcome. Prior knee 
injury resulted in a lower Lysholm after APM in women, in men however no such association 
was found.
3) CONFLICTING EvIDENCE
Age at baseline
The influence of age on clinical outcome following APM was investigated in 11 studies. 
In two studies 25,48, patients were divided into two groups; under 30 years old and above 
30 years old. One article 36 divided patients in a group under and above 40 years. In the 
remaining studies, the method for defining age subgroups was not specified. Five studies 
found a worse clinical outcome for older patients, and six studies did not find a statistically 
significant association.
Body Mass Index
Seven studies described the association between Body Mass Index (BMI) and clinical out-
come. Four of them reported a worse Lysholm score for overweight or obese patients. The 
remaining studies found no association between BMI and clinical outcome. When we looked 
at studies with patients above 45 years old, we found evidence for the fact that there is no 
association between BMI and clinical outcome of APM.
Leg malalignment
The predictive value of leg malalignment was described in three studies. One of them 38 re-
ported a statistical significantly worse Modified Lysholm score for patients with a valgus mal-
alignment (tibiofemoral angle more than 4 degrees on anteroposterior full leg radiograph). 
However, two studies 22,43 found no significant association between leg malalignment and 
outcome.
Chondral damage during arthroscopy
Ten studies investigated the association between chondral damage found during surgery 
and clinical outcome. Three of them used the Outerbridge 50 classification, two of them the 
ICRS (International Cartilage Repair Society 51) classification, and the remaining studies only 
mentioned whether chondral damage was found during arthroscopy or not. Six out of ten 
studies reported that the presence of chondral damage predicted a worse clinical outcome, 
and four studies did not find such an association. The relationship between chondral damage 
and clinical outcome seems to be driven by age; when we looked at studies with patients 
above 45 years old (n = 4), all studies reported a worse outcome for patients with chondral 
damage during arthroscopy. Looking at studies with patients below 45 years old (n = 6), 
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almost all studies reported no association between chondral damage and outcome. Further-
more, when specifically looking at medial meniscal tears, chondral damage seems to be a 
prognostic factor for worse outcome as well.
DISCuSSION
Despite the extensive heterogeneity in study design, in the definition of subgroups and in 
outcome measurements, several prognostic factors were found for the clinical outcome after 
APM. We found moderate evidence that a larger amount of resected tissue, the presence of 
radiological knee OA at baseline, and a longer duration of complaints are associated with 
a worse clinical outcome following APM. Sex, the preoperative sport level, onset (traumatic 
versus degenerative), and the type of meniscal tear do not seem to influence clinical out-
come. It should be noted that, the phrasing ‘’worse outcome’’ does not necessarily mean 
that the outcome is unsatisfactory. It means that, having a specific factor is associated with a 
worse patient-reported outcome compared to not having this specific factor.
To the best of our knowledge, this is the first systematic review that focuses specifically on 
predictors for the clinical outcome following APM. Salata and colleagues 52 conducted a 
systematic review in 2010 on the radiological and clinical outcome in patients undergoing 
meniscectomy. The authors primarily assessed outcome measurements of APM in general, 
but also described some features which might influence this outcome. One of their outcomes 
was, that degenerative meniscal tears are statistically significant associated with a nega-
tive postoperative outcome. This is a very relevant finding, as most APMs are performed in 
middle-aged and elderly patients, who typically have degenerative meniscal tears 5,53-55. The 
findings of Salata are in concordance with Englund et al. 56, who found that degenerative 
meniscal tears result in worse clinical and radiological outcome after 16 years in 155 patients 
undergoing APM. By contrast, a recently published and methodologically robust study of 
Thorlund et al. 57. reported no clinically relevant difference in patient reported knee function 
and –satisfaction between degenerative and traumatic meniscal tears after 12 months. This 
is in line with the results of the current systematic review, in which no difference in patient 
reported clinical outcome between degenerative and traumatic tears was found as well. 
Thus, the predictive value of degenerative versus traumatic meniscal tears for the clinical 
outcome following APM is questionable and needs to be further unraveled.
A factor that does seem to influence clinical outcome following APM, is the duration of 
symptoms. Although a short duration of symptoms (less than six weeks) is one of the clinical 
variables that orthopedic surgeons consider to be important in surgical decision making 
58, robust evidence regarding the impact of timing awaiting for APM on clinical outcome 
is scarce. The fact that there is no standard definition of ‘’acute’’ and ‘’chronic’’ symptoms 
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causes a substantial amount of heterogeneity between studies, which makes them difficult 
to compare. Nonetheless, in the present systematic review, moderate evidence was found 
that a longer duration of symptoms (longer than 3-12 months) is associated with a worse 
clinical outcome following APM.
A third key-finding concerns the amount of resected meniscal tissue during arthroscopy, 
which appeared to be a relevant factor in predicting the clinical outcome following APM. This 
is not surprising, given the critical biomechanical role of the meniscus within the knee joint 
59. Our study suggests that the amount of resected meniscal tissue is negatively associated 
with postoperative clinical outcome following APM, in concordance with Englund 56 and 
Salata 52. More specifically, resecting more than 50% of meniscal tissue, leaving less than 
3 mm meniscal width and impairing the peripheral third (the meniscal rim) were found to 
be associated with worse clinical outcome. In conclusion, resecting more meniscal tissue is 
associated with worse clinical outcome after APM.
Whereas no association was found between degenerative meniscal tears (compared to 
traumatic tears) and a worse clinical outcome following APM, our study does show that 
radiological knee OA at baseline is associated with a worse clinical outcome. This is in line 
with the results of Kirkley and colleagues 60, showing that arthroscopic surgery for patients 
suffering knee OA, may not lead to satisfactory outcomes. The interesting thing is that a 
degenerative meniscal tear, as described earlier, does not seem to be associated with a worse 
clinical outcome following APM. As degenerative meniscal tears are often considered to 
be a signifying feature of incipient knee OA 61-63, one might expect that this type of tear, 
compared to traumatic meniscal tears, has a negative association with clinical outcome as 
well. Further investigation into this topic, for example using novel imaging techniques which 
provide quantitative information regarding the degree of meniscal degeneration 64, is desired.
Another relevant knee-specific factor that we studied, is chondral damage during surgery. 
Symptomatic degenerative meniscal tears are frequently associated with cartilage damage 
to the corresponding articular surfaces 65,66. In the current systematic review, conflicting 
evidence was found for the predictive value of chondral damage on clinical outcome after 
APM.. However, subgroup analysis showed that, when looking at the studies in patients 
with a mean age of < 45 years, no association was found between chondral damage and 
outcome. For the studies in patients with a mean age of > 45 years, we did find that chondral 
damage at time of surgery is associated with a worse clinical outcome. A study by Sofu et 
al. 67, in which patients above 60 years old with traumatic meniscal tears were included, 
reported worse pain scores for patients with chondral damage as well. Thus, it is likely that 
chondral damage in patients aged above 45 years has a negative influence on clinical out-
come following APM, however this association needs to be further investigated.
Another factor that could potential be of influence on clinical outcome, is whether the 
tear is located in the lateral- or the medial meniscus. However, this factor was studied in only 
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one of the included publications, which did not find an association. As a potential prognostic 
factor needs to be described in at least two studies, according to the Best Evidence Syntheses 
principle, no conclusions regarding the predictive value of medial versus lateral meniscecto-
mies can be drawn. This factor is particularly relevant as in literature, lateral meniscectomy 
has been reported to result in poorer postoperative outcome than medial meniscectomy 
52,68-70. A hypothesis is that the lateral meniscus is ‘’less conforming’’ than the medial menis-
cus after meniscectomy, resulting in an increased amount of instability and resultant force 
transmission to the articular cartilage. By all means, the predictive value of this factor too 
warrants further investigation.
A major strength of the present study is that we performed an extensive search in all relevant 
databases by aid of an experienced biomedical information specialist of the medical library of 
our institution. Furthermore, all steps in this systematic review were performed in duplo and 
acknowledged tools for the assessment of the risk of bias and data extraction were used. A 
limitation of our systematic review is that, despite the large amount of found publications, 
relatively few studies could be included in this systematic review. This is a consequence of 
our selection strategy, involving extensive exclusion criteria. To increase the a priori chance of 
acquiring reliable and comparable results (and potential conduct a meta-analysis) we defined 
concrete, well justified and clearly stated eligibility criteria. For example, we only included 
articles using validated questionnaires, such as the Lysholm- or IKDC (International Knee 
Documentation Committee71) score. Publications using outcome measures such as ‘’percent-
age of satisfied patients’’ were therefore excluded. The rationale of this exclusion criterion 
is the relatively low reliability and reproducibility of non-validated patient reported outcome 
measurements. Although we might have missed information about prognostic factors, we 
believe that this approach increased the reliability of our results.
Another limitation of this systematic review is, that only rough estimations of the effect size 
of the found prognostic factors could be provided. This is due to the fact that a substantial 
amount of heterogeneity in the definition of subgroups and outcome measurements was 
found. For example, the potential influence of the type of meniscal tear on clinical outcome 
following APM was reported in nine studies, however none of them described a classification 
system for the type of tear. In fact, six of them did not provide any information regarding 
the definition of meniscal tear subgroups at all. Also, in many of the included studies the 
outcome of subgroups was poorly described. Often only P values were reported; some stud-
ies did not even provide a P value but only described the prognostic value of a specific factor 
(e.g. ‘’No significant correlation was found between the amount of tissue resected and the 
subjective, clinical and radiological outcome’’ 46). Given the found heterogeneity and inad-
equately described subgroup results, pooling of study results and performing a meta-analysis 
were not justified. This implied that small studies might not have reported an association 
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based on lower power while pooled results the reported association would have counted in 
the overall estimation for the association.
Despite the high amount of APMs performed worldwide, there is a lack of consensus on the 
indications for this procedure, particularly in younger and middle-aged patients. To enable 
a more evidence-based approach in surgical decision making, knowledge of the predictive 
value of certain patient-specific factors for the clinical outcome is essential. In this compre-
hensive systematic review, prognostic factors for the patient-reported outcome of APM were 
assessed. We have shown that, based on the best available evidence, radiographic knee 
OA at baseline, a long duration of complaints, and resecting more meniscal tissue during 
arthroscopy are associated with a worse postoperative clinical outcome. The findings could 
contribute to the development of a prediction model for the clinical outcome of APM, based 
on patient-specific factors, which could guide orthopedic surgeons in their clinical decision 
making. However, within the available literature, the earlier mentioned heterogeneity and 
inadequately reported subgroup outcomes make it challenging to draw adequate conclu-
sions. Therefore, there is an urgent need for more well-designed, robust clinical trials on 
arthroscopic meniscal surgery using validated patient reported outcome measurements and 
with relevant, a priori defined subgroups.
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SuPPLEMENTARY MATERIAL 1: COMPLETE SEARCH
Database: original hits: Without duplicates:
Embase.com 3630 3554
Medline (OvidSP) 3179 806
Web-of-science 1231 363
Cochrane 181 3
SPORTDiscus (Ebsco) 620 79
Google Scholar 200 59
Total 9041 4864
Embase.com:
(‘knee meniscus rupture’/de OR (‘knee meniscus’/de AND (rupture/exp OR ‘knee injury’/exp)) 
OR meniscectomy/de OR ((menisc* NEAR/6 (tear* OR rupture* OR injur* OR lesion* OR 
damage* OR trauma* OR torn)) OR meniscopath* OR meniscectom* ):ab,ti) AND (therapy/
exp OR ‘treatment outcome’/exp OR exercise/exp OR surgery/exp OR arthroscopy OR reha-
bilitation/exp OR therapy:lnk OR rehabilitation:lnk OR surgery:lnk OR (therap* OR treat* 
OR conservativ* OR physiotherap* OR kinesiotherap* OR kinesitherap* OR exercise* OR 
surg* OR nonsurg* OR postsurg* OR meniscectom* OR remov* OR resect* OR operati* OR 
postoperati* OR nonoperati* OR rehabilitat*):ab,ti) AND (prognosis/de OR ‘follow up’/de 
OR ‘cohort analysis’/de OR ‘longitudinal study’/de OR ‘retrospective study’/de OR ‘prospec-
tive study’/de OR (prognos* OR ‘follow up’ OR followup OR cohort* OR longitudinal OR 
retrospective OR prospective OR ‘long term’ OR ‘medium term’ OR ‘late results’):ab,ti) NOT 
([animals]/lim NOT [humans]/lim)
Medline (ovidSP):
(Menisci, Tibial/in OR (“Menisci, Tibial”/ AND (rupture/ OR “Knee Injuries”/)) OR ((menisc* 
ADJ6 (tear* OR rupture* OR injur* OR lesion* OR damage* OR trauma* OR torn)) OR 
meniscopath* OR meniscectom* OR arthroscopy).ab,ti.) AND (exp therapeutics/ OR exp 
“treatment outcome”/ OR exp exercise/ OR exp “Surgical Procedures, Operative”/ OR exp 
rehabilitation/ OR rehabilitation.xs. OR therapy.xs. OR surgery.xs. OR (therap* OR treat* OR 
conservativ* OR physiotherap* OR kinesiotherap* OR kinesitherap* OR exercise* OR surg* 
OR nonsurg* OR postsurg* OR meniscectom* OR remov* OR resect* OR operati* OR post-
operati* OR nonoperati* OR rehabilitat*).ab,ti.) AND (prognosis/ OR exp “cohort studies”/ 
OR (prognos* OR “follow up” OR followup OR cohort* OR longitudinal OR retrospective OR 
prospective OR “long term” OR “medium term” OR “late results”).ab,ti.) NOT (exp animals/ 
NOT humans/)
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Cochrane:
(((menisc* NEAR/6 (tear* OR rupture* OR injur* OR lesion* OR damage* OR trauma* OR 
torn)) OR meniscopath* OR meniscectom* ):ab,ti) AND ((therap* OR treat* OR conservativ* 
OR physiotherap* OR kinesiotherap* OR kinesitherap* OR exercise* OR surg* OR arthros-
copy OR nonsurg* OR postsurg* OR meniscectom* OR remov* OR resect* OR operati* 
OR postoperati* OR nonoperati* OR rehabilitat*):ab,ti) AND ((prognos* OR ‘follow up’ OR 
followup OR cohort* OR longitudinal OR retrospective OR prospective OR ‘long term’ OR 
‘medium term’ OR ‘late results’):ab,ti)
Web-of-science:
TS=((((menisc* NEAR/6 (tear* OR rupture* OR injur* OR lesion* OR damage* OR trauma* 
OR torn)) OR meniscopath* OR meniscectom* )) AND ((therap* OR treat* OR conservativ* 
OR physiotherap* OR kinesiotherap* OR kinesitherap* OR exercise* OR surg* OR arthros-
copy OR nonsurg* OR postsurg* OR meniscectom* OR remov* OR resect* OR operati* OR 
postoperati* OR nonoperati* OR rehabilitat*)) AND ((prognos* OR “follow up” OR followup 
OR cohort* OR longitudinal OR retrospective OR prospective OR “long term” OR “medium 
term” OR “late results”)) NOT ((animal* OR rabbit* OR mouse OR mice OR rat OR rats 
OR canine OR dog OR dogs OR sheep OR cat OR cats OR horse* OR bovine OR goat* OR 
porcine* OR pig OR swine) NOT (human* OR patient*)))
SPorTDiscus (Ebsco):
(DE “meniscus (Anatomy) - Wounds & injuries” OR ((menisc* N6 (tear* OR rupture* OR 
injur* OR lesion* OR damage* OR trauma* OR torn)) OR meniscopath* OR meniscectom* )) 
AND (DE therapeutics+ OR DE “treatment outcomes+” OR DE exercise+ OR DE “OPERATIVE 
surgery+” OR DE rehabilitation+ OR (therap* OR treat* OR conservativ* OR physiotherap* 
OR kinesiotherap* OR kinesitherap* OR exercise* OR surg* OR arthroscopy OR nonsurg* 
OR postsurg* OR meniscectom* OR remov* OR resect* OR operati* OR postoperati* OR 
nonoperati* OR rehabilitat*)) AND (DE “cohort analysis+” OR (prognos* OR “follow up” OR 
followup OR cohort* OR longitudinal OR retrospective OR prospective OR “long term” OR 
“medium term” OR “late results”)) NOT (DE animals+ NOT DE humans)
PubMed publisher:
(((menisc*[tiab] AND (tear*[tiab] OR rupture*[tiab] OR injur*[tiab] OR lesion*[tiab] OR 
damage*[tiab] OR trauma*[tiab] OR torn)) OR meniscopath*[tiab] OR meniscectom*[tiab] 
)) AND ((therap*[tiab] OR treat*[tiab] OR conservativ*[tiab] OR physiotherap*[tiab] OR 
kinesiotherap*[tiab] OR kinesitherap*[tiab] OR exercise*[tiab] OR arthroscopy OR surg*[tiab] 
OR nonsurg*[tiab] OR postsurg*[tiab] OR meniscectom*[tiab] OR remov*[tiab] OR resect*[tiab] 
OR operati*[tiab] OR postoperati*[tiab] OR nonoperati*[tiab] OR rehabilitat*[tiab])) AND 
((prognos*[tiab] OR follow up*[tiab] OR followup[tiab] OR cohort*[tiab] OR longitudinal[tiab] 
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OR retrospective[tiab] OR prospective[tiab] OR long term*[tiab] OR medium term*[tiab] OR 
late result*[tiab] )) AND publisher[sb]
Google scholar:
“meniscus|meniscal tear|rupture|ruptures|injury|lesions|trauma” therapy|treatment|exerci
se|surgery|therapuetic|rehabilitation|surgery|arthroscopy|surgical|meniscectomy|operative 
prognosis|”follow up”|cohort|longitudinal|retrospective|prospective|”long|medium term”
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PART I: IMAGING OF MENISCAL PATHOLOGY
Advances in MRI techniques have made great progress in recent years, providing new and 
better ways of visualizing meniscal pathologies. In particular, quantitative MRI (qMRI) tech-
niques, such as T2 mapping are promising in musculoskeletal research. These techniques have 
the capacity to non-invasively show subtle changes in biochemical tissue composition and 
open the door to early stage detection of meniscal degeneration, knee OA and other joint 
pathologies 1-6. T2 mapping and other advanced MRI techniques have a tremendous potential 
in musculoskeletal imaging, however the usefulness of these techniques in clinical practice 
and implications for further treatment depends on their validity, reproducibility, responsive-
ness, and feasibility. The general aim of Part I of this thesis is to gain more insight into these 
features; they will be discussed in more detail in the next paragraphs.
Validity of T2 mapping for meniscus
In musculoskeletal imaging, T2 mapping was originally developed for articular cartilage 2,7,8. 
Consequently, this technique has become widely studied to quantitatively assess cartilage de-
generation. A recent systematic review on articular cartilage qMRI techniques reported good 
to excellent reproducibility and discriminative validity to distinguish degree of degeneration 
for T2 mapping 4. T2 mapping of the meniscus is relatively new 9-11. As a result of its tightly or-
ganized collagen structure, the meniscus has relatively shorter T2 components than those of 
cartilage, resulting in lower T2 relaxation times. The T2 relaxation time (in this thesis referred 
to as “T2 value”) of certain tissue represents the time protons take to return to their original 
(i.e., resting) state. Meniscal T2 relaxation times of healthy subjects are around 11 ms 11,12; at 
the bottom end of the range of echo time values in standard spin echo based T2 mapping 
sequences in musculoskeletal research (often ranging from 10-100 ms) 6. Due to the short 
T2, and the heterogeneity of meniscal tissue, concerns have been raised in previous studies 
that standard spin echo based T2 mapping is not suitable to measure T2 of the meniscus 13-17.
These concerns were addressed in a study by Nebelung et al., who validated several menis-
cal qMRI techniques (including T2 mapping) with histology 9; the gold standard for tissue 
changes. For T2 mapping, the authors reported a correlation coefficient of 0.65. It should 
be noted, however, that T2 measurements were performed ex vivo. That is, T2 mapping 
was performed after the menisci were removed from the knee. During ex vivo experiments, 
meniscal T2 relaxation times may be influenced by storage processes (e.g., alterations in 
tissue hydration) 9,10 or the temperature in the scanning room (usually room temperature 
instead of body temperature) 9. Ex vivo studies may therefore result in a lower value of cor-
relation. Moreover, in the study by Nebelung et al., the authors pointed out that T2 sequence 
parameters used in their study (e.g., echo time values started at 10.4 ms), might not have 
been optimal for meniscal T2 measurements, which is understandable given the broad range 
of qMRI outcome parameters they measured.
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To overcome these limitations, we performed an in vivo meniscal T2 mapping validation 
study. To our knowledge, this study, described in Chapter 2, is the first to assess meniscal 
T2 mapping in vivo against histology. We prospectively assessed meniscal tissue, obtained 
during total knee replacement surgery from patients with knee OA, and found a strong 
correlation (R = 0.86) between T2 values and histological grade of degeneration. Although 
these results must be interpreted with care given the relatively small sample size (21 meniscal 
regions from 13 menisci), these findings do suggest that meniscal T2 measurements are 
accurate using standard spin echo based T2 mapping. It should be noted that great care must 
be taken when choosing MRI sequence parameters, especially regarding echo time values. 
Preferably, one should use echo time values starting relatively low (< 5 ms).
We have to point out that our validation study was performed only in OA patients, and these 
findings might not be applicable in the same way across other patient groups. In future 
research, validation of in vivo meniscal T2 mapping in other patient groups is needed. We 
are currently collecting data (MRI and histology) of patients with traumatic meniscal tears 
(e.g., STARR trial patients). Preliminary results (not yet published) suggest a strong correlation 
between T2 measurements and histological degree of degeneration in the retrieved menisci 
of these patients. An important challenge in this context lies in the image post processing 
and analysis of T2 mapping, in particular, the question of exactly how to handle menis-
cal tears in segmentation. It seems logical to exclude the actual tear while segmenting the 
meniscus, as that specific area on MRI does not represent meniscal tissue. However, it needs 
to be acknowledged that potential bias can occur because of misinterpretation of meniscal 
tears due to anatomic variants, artefacts, post-traumatic changes, or post-surgical meniscal 
changes (i.e., after APM) 18-20. The latter factor, meniscal changes after APM, is particularly 
relevant given the tremendous number of APMs performed worldwide 21,22.
Another limitation of our validation study is the lack of zonal differentiation, for instance 
between radially inner (often called white) and outer (often called red) zones and between 
deep and superficial zones. Although no consensus exists regarding the exact pattern, 
several studies have reported that there are regional differences regarding meniscal tissue 
composition and biomechanical properties 10,13,23. Our study results provide an overall estima-
tion of good accuracy for meniscal T2 mapping, although findings may not be representative 
for meniscal subregions. The rationale behind our approach was that the Pauli score (which 
we used for histological grading) does not distinguish meniscal zones, and, accordingly, the 
entire cross-section needs to be assessed 24. Hence, a separate score for different meniscal 
zones was not possible. Future studies should be performed to evaluate the diagnostic per-
formance of meniscal T2 mapping in different zones 25. Also, given the fairly large number of 
different qMRI methods available (compositional techniques such as T2 mapping and T1r as 
well as measures for volume and thickness 9,11,26,27), the research community should strive for 
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a standardized algorithm regarding the application of these techniques in musculoskeletal 
research.
reproducibility of T2 mapping in a multicenter setting
In the STARR trial, T2 mapping is used as outcome measure for early cartilage degeneration 
two years after meniscal injury. In such a multicenter study, knowledge of reproducibility 
of T2 measurements is critical. Two aspects of reproducibility are relevant in this setting: 1) 
longitudinal reproducibility of T2 measurements and 2) cross-validation of T2 values across 
centers.
1) Longitudinal reproducibility (sometimes referred to as repeatability or test-retest) of T2 
measurements is crucial for distinguishing between true T2 changes and random error. In 
general, a good to excellent longitudinal reproducibility is reported for cartilage T2 mapping 
4,28,29. The majority of reports in this context, however, are single-site studies. Few studies 
have assessed longitudinal reproducibility of cartilage T2 mapping in a multicenter setting 
4; generally using a single type of MRI scanner and harmonized acquisition protocols. This 
approach is optimal from an imaging perspective and provides valuable information for 
future use of T2 mapping. However, one should realize that often various scanner types are 
present when performing a multicenter study, similar to clinical practice. In the STARR trial, 
for instance, various types of MRI scanners are present in the participating centers. Moreover, 
local requirements and restrictions regarding MRI acquisition in participating centers may 
prevail over optimal imaging strategy, especially in large multidisciplinary clinical trials, in 
particular regarding scan time. All these factors emphasize the importance of evaluating 
longitudinal reproducibility of T2 mapping in a multivendor setting, that is, using different 
MRI systems and acquisition protocols. In Chapter 3, a prospective pilot study is described 
assessing the reproducibility of cartilage T2 measurements in four traveling volunteers over a 
6-month-interval in a multicenter setting, using different MRI systems and sequence param-
eters. Volunteers were scanned on one day at five hospitals, and the same experiment was 
performed 6 months later. A good to excellent longitudinal reproducibility was found (ICCs 
ranging from 0.73 - 0.91 and RMS-CVs ranging from 1.1 - 1.5%). It should be noted that 
in this work, only healthy volunteers were studied. For future use of cartilage T2 mapping as 
biomarker for (early) cartilage degeneration, it is essential to evaluate its responsiveness to 
change in patients suffering from OA and similar conditions.
2) Cross-validation of T2 values in multicenter studies is important for assessing comparability 
of T2 values across centers. As described in Chapter 3 and in agreement with previous 
studies, T2 values from different MRI scanners and from different vendors show consider-
able differences 30-32. Several factors could have played a part in this issue, including coil 
type (in particular receive only versus receive and transmit coils) 33,34, magnetic field strength 
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32,35,36, and T2 mapping sequence variations (such as FSE versus SE and 3D versus 2D) 31,37,38. 
T2 mapping has considerable potential in musculoskeletal imaging, in particular given its 
feasibility in many types of scanners, yet the inter-scanner variation in T2 values remains a 
matter of concern. Although beyond the scope of this thesis, future studies are needed to 
investigate the underlying causes of the differences in T2 values across scanners and T2 map-
ping sequences. Understanding these differences is critical for establishing common grounds 
and providing T2 mapping protocols that generate comparable T2 values across scanners. For 
now, it is important to realize that T2 values obtained in different scanners should not be 
compared, nor pooled. In a study such as the STARR trial, one should focus on intra-subject 
change in T2 values over time rather than absolute values of mean T2 values across subject 
groups.
Feasibility of (q)Mri: reducing scan time
MRI allows evaluation of the whole knee, making it ideally suited to diagnose and monitor a 
broad range of musculoskeletal disorders 1,27. MRI examination of the knee is, however, time 
consuming, especially when adding quantitative sequences such as T2 mapping. Standard 
MRI knee protocol, including routine clinical sequences as well as T2 mapping, typically takes 
about 30-45 minutes 12,39. MRI examinations of the knee constitute a significant financial 
burden for societies; therefore, developing more streamlined protocols and accelerating im-
age acquisition is therefore highly relevant 39. Reducing scan time can not only save costs, it 
can also increase efficiency and patient comfort of MRI examinations 40. 
In Chapter 4, we evaluated a promising new MRI technique to reduce scan time: the recently 
developed quantitative double-echo steady-state (qDESS) sequence. qDESS has the potential 
to provide diagnostic images and quantitative measurements of the knee in less than five 
minutes scan time 40,41. Proof-of-concept of qDESS for T2 mapping of cartilage and meniscus 
and structural knee imaging (using MOAKS) has been provided by Chaudhari et al. 40. Focus-
ing on healthy subjects, they validated qDESS against routine methods for T2 mapping and 
MOAKS and reported high diagnostic performance for both cartilage and meniscus. Also, a 
pilot study in 10 patients with knee OA, performed in the same work, provided promising 
qDESS outcomes, suggesting that accurate knee OA measurements are possible with qDESS.
Building upon the work of Chaudhari et al., we further assessed the construct validity 
of quantitative and structural (semi-quantitative) qDESS-based biomarkers, in a larger OA 
cohort against radiography, widely accepted as the gold standard for OA knee imaging. 
We evaluated semi-quantitative MOAKS scores and T2 measurements of the knee cartilage 
and meniscus in a clinical OA population (n = 53). The study population reflected a mix of 
different grades of OA severity: Kellgren-Lawrence Grade (KLG)0, KLG2 and KLG3 42. In 
contrast to the approach of Chaudhari et al., which encompassed global assessment of 
cartilage and meniscus, we evaluated predefined subregions. This is relevant as OA is a 
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focal disease; regions are not affected in the same rate and at the same time 43-47. We 
demonstrated that T2 mapping and structural (semi-quantitative) MRI knee assessment with 
MOAKS can distinguish between radiographic degree of OA, and that T2 values were similar 
to the literature values 11,12,29,48. The strongest correlations of qDESS with KLG was found in 
the medial femoral cartilage and medial posterior meniscal horn. These regional patterns 
were in line with previous work 3,49,50.
Our results highlight the potential value of qDESS for knee (OA) imaging and provide an 
important step in the further development and implementation of this technique. Further 
evaluation and validation of qDESS is needed, in particular, regarding the sensibility of qDESS 
to detect abnormalities in knee structures other than cartilage and meniscus, such as bone 
marrow lesions (BMLs, which can be a feature of OA or traumatic injury). In the literature, 
concerns have been raised that qDESS images underestimate the size of BMLs, possibly as a 
result of T2* susceptibility effects 39,51. Separation of the two qDESS echoes might improve 
accuracy for BML detection 40,52, yet further optimization is needed.
So far, qDESS studies have focused on knee OA; however, whether these results can be 
extended to other patient groups, is not clear. Thus, once qDESS is further optimized, it 
should be tested in musculoskeletal disorders other than OA. Another important limitation 
of qDESS studies so far is that only cross-sectional evaluation has been performed. The lack 
of a longitudinal aspect to these studies limits interpretation regarding its potential use in 
clinical trials.
Ultimately, one fast scan combining diagnostic image quality with qMRI, such as qDESS, 
may surpass traditional, time consuming MRI protocols. Deep learning-based methods for 
qDESS may further reduce scan time. This will allow more patients to be scanned within the 
existing workforce, thereby having tremendous implications for large-scale clinical studies 
and, potentially, clinical practice.
PART II: ETIOLOGY AND TREATMENT OF MENISCAL PATHOLOGY
The general aim of Part II of this thesis was to gain more insight into the role of meniscus 
damage in the development of knee OA, the classification “traumatic versus degenerative” 
tears, and into treatment strategies for meniscal pathology; they will be discussed in more 
detail in the next paragraphs.
The role of meniscus damage in knee oA: cause or consequence?
The fascinating role of the menisci in knee OA has increasingly gained attention from re-
searchers worldwide. Not only can meniscal damage in an otherwise healthy knee lead to 
the development and progression of knee OA, knee OA might also lead to meniscal damage, 
which in turn can accelerate OA processes 53-61.
Chapter 9
162
A generally accepted hypothesis is that due to morphological damage or extrusion, the 
meniscus may lose its critical biomechanical function load distribution and weight-bearing 
capacities within the knee joint are affected. Peak load may increase with 40 - 700% in the 
medial compartment 57, which may result in cartilage damage 54,62. Cartilage loss may in turn 
cause further meniscal damage, creating a vicious circle of OA progression 54,55.
Exact pathophysiological processes in the development of knee OA and the complex 
interplay between different structures such as cartilage and menisci, however, remain largely 
unknown 63. In particular, little consensus exists regarding the question of whether meniscal 
damage of cartilage damage comes first in the development of OA. According to some 
researchers, meniscal damage is the first sign of knee OA as MRI-confirmed meniscal dam-
age often occurs prior to visible cartilage damage and as knees with meniscal damage, 
but without cartilage degradation, are at considerably higher risk of developing knee OA 
than knees with healthy menisci 43,53,57,64. This view, however, is not generally accepted. 
Other researchers suggest that OA development starts with changes in cartilage, resulting in 
meniscal damage 65, or that meniscal damage and cartilage degradation occur in parallel as 
independent processes 66. Due to difficulties in accurately monitoring the disease processes in 
vivo and the slow development of OA, studying such disease processes and spatial relation-
ships is challenging 67.
To overcome this limitation, animal OA models are often used to gain knowledge of the 
pathophysiology and temporal sequence in OA development 66. In an anterior cruciate liga-
ment resected (ACLT) rabbit model for knee OA, meniscal damage has been found to occur 
prior to cartilage changes 68. Contrary to what was suggested in the rabbit model, a study by 
Smith et al. using a dog ACLT model, has suggested that gross cartilage degradation occurs 
prior to gross meniscal damage 65.
In Chapter 5, we explored the relationship between cartilage and meniscus damage in the 
course of knee OA development in a collagenase-induced OA (CIOA) mouse model. Our 
study is the first to evaluate meniscal degeneration in the CIOA model. With this approach, 
OA is induced by an intra-articular injection of the enzyme collagenase 69,70. Collagenase 
modifies the extracellular matrix of ligaments and other knee structures, inducing joint insta-
bility which subsequently causes knee OA. An advantage of this approach is, that the menisci 
are left untouched in inducing OA in the CIOA model, contrary to the surgical destabilization 
of the medial meniscus (DMM) mouse model (which is also frequently used as OA model) 71. 
In our study, meniscal damage and cartilage damage appeared around the same time (2-4 
weeks after OA induction). Furthermore, meniscal extrusion was observed early in the course 
of OA, from day 1 onwards.
These findings support the theory that meniscal extrusion, by altering load distribution 
within the knee joint, is an early sign of knee OA. Our findings must, however, be interpreted 
with caution as the findings of our mouse study might not apply in the same way to the 
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human knee. Also, it should be noted that the potential influence of the OA induction 
method (e.g. CIOA, DMM) on pathophysiological processes in OA and meniscal extrusion 
is not clear. Moreover, in general, meniscal extrusion is considered a radiographic (i.e., MRI-
based) feature 62,72,73, but there is little evidence on histology-based meniscal extrusion.
It is clear that further research is required on the cascade in the development of knee OA 
and the temporal sequence of meniscal and cartilage damage during the course of OA. 
Understanding these processes is essential to developing and improving treatment strategies 
and, potentially, even prevention of knee OA. Future research should preferably be performed 
in vivo; after all, biomechanical and morphological features of the human knee differ from 
those of most animal knees 24,74. In this context, qMRI techniques, such as T2 mapping, may 
play an important role by allowing detection of very subtle changes in biochemical tissue 
composition in a non-invasive way Chapter 2. Especially T2 mapping has high potential for this 
purpose as it does not require special MRI hardware 39. Largescale longitudinal evaluation is 
needed to unravel disease pathways in the development of knee OA. The interplay between 
knee structures and the relation to biomechanical, inflammation and clinical features (e.g., 
knee pain) should be studied taking a comprehensive approach, involving all relevant knee 
structures and defined subregions.
The continuum theory of meniscal degeneration
In clinical decision making for meniscal pathology, in particular, in choice of treatment 
strategy, classifying meniscal tears as degenerative and traumatic tears plays a major role 
55,75,76. It must be recognized, however, that there is no consensus on how exactly to define 
“degenerative” versus “traumatic” tears. In fact, no strict morphological criteria exist to 
distinguish a degenerative from a traumatic meniscal tear; differentiation between those two 
types of tears can therefore be challenging. For instance, sometimes traumatic tears are a 
consequence of a very minor trauma (e.g., a misstep), and, on the other hand, degenerative 
tears can be present in what seems an otherwise ‘’healthy’’ knee” 77,78. Also, meniscal tears 
are frequently observed incidental findings when performing knee MRI, without causing 
knee complaints 78. Thus, differentiation between those two main types of tears is not as 
straightforward as it may seem.
Instead of the traditional classification of “degenerative” versus “traumatic” tears, one 
could think of a continuum from a healthy meniscus to a degenerative meniscus (Figure 
1). In this theory, the chance of a “traumatic meniscal tear” depends on the degree of 
degeneration of the meniscal tissue: the more the degeneration, the higher the chance of a 
torn meniscus in the context of a traumatic event. This perspective would explain why some-
times a “traumatic meniscal tear” is seen following minor, low energy trauma 77. A previous 
study has reported that traumatic meniscal tears may result from early degenerative disease 
processes, supporting the continuum hypothesis 79. We performed a comprehensive, cross-
sectional histology-based study, described in Chapter 6, using human meniscal tissue, to 
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test this hypothesis. Meniscal tissue from patients with traumatic meniscal tears (i.e., STARR 
trial participants) was compared to tissue from patients with acute transfemoral amputations 
with no history of knee injury (i.e., “healthy meniscal tissue”). Meniscal tissue from patients 
suffering from knee OA (i.e., “degenerative tissue”) was used as reference standard. The 
study revealed that traumatically torn meniscal tissue showed a higher histological degree of 
degeneration compared to healthy meniscal tissue, thus, supporting the continuum theory.
Given the histology-based study design, longitudinal follow-up of meniscal tissue was not 
possible in our study; after all, meniscal tissue was histologically analyzed after resection. 
Although the potential influence of time-interval between injury and surgery was properly 
addressed (the statistical model was corrected for this factor), the lack of longitudinal assess-
ment of tissue behavior should be acknowledged.
Thus, our results provide an important first step in testing the continuum theory of meniscal 
degeneration; however, findings need to be interpreted with care. Future research is required 
to understand how the biochemical composition of menisci changes from healthy tissue to 
different stages of degeneration and tears in knee OA and knee symptoms. In this context, 
one should realize that not all degenerative meniscal tears are symptomatic; thus, other 
factors must play a role in the production of symptoms.
Also, further work is needed to assess whether the continuum is two sided. If two sided, 
it would mean that meniscal tissue degeneration is more or less reversible, whether or not 
region-dependent. This hypothesis is supported by the finding that meniscal tissue is able 
to replace proteoglycans in early stage OA 80 and by the relatively high healing rates after 
meniscal repair reported in the literature, especially for tears in the red zone 81,82. A study by 
Rubman and colleagues 83 reported that even tears that extend into the white (i.e., avascu-
lar) zone have the potential to fully heal after meniscal repair, especially longitudinal tears 
(though healing rates are lower compared to tears limited to the red zone). Tears in the 
lateral meniscus seem to heal better than tears in the medial meniscus 84. It should be noted, 
however, that little consensus exists regarding what exactly comprises “full healing” after 
repair (e.g., absence on tear in intra-meniscal region, or 90% full thickness apposition of the 
original tear occurred with less than 10% of the tear remaining). Moreover, healing on MRI, 
healing in a second-look arthroscopy, and clinical healing (i.e., absence of symptoms) should 
not be assumed to be the same and are not necessarily correlated 83,85,86. Further research on 
the continuum theory and what exactly happens on the molecular level is greatly needed, 
along with research on how those tissue changes are displayed in imaging parameters. In this 
context, great potential lies in the in vivo application of qMRI techniques such as T2 mapping; 
to gain a deeper understanding of tissue behavior and further characterization of zonal 
differences. Ultimately, such knowledge may also contribute to clinical decision making for 
meniscal repair (e.g., to predict the chance of successful healing after repair based on tissue 
quality) and to the accurate assessment of healing response after repair.
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Clinical decision making in meniscal pathology: conservative versus 
arthroscopic treatment
“If it is torn, take it out, take it all out. Even if you just think it’s torn, take it out”. This 
statement by Smillie et al. in 1967 reflects the common approach to manage meniscal tears 
half a decade ago; total meniscectomy 60,87,88. Since then, biomechanical studies and surgi-
cal outcome assessments, in particular regarding the substantially increased risk of knee 
OA after total meniscectomy, have increased our understanding of meniscal function and 
pathology 89-93. Around the 1970’s, when arthroscopic techniques were first introduced, a 
shift took place from total meniscectomy to removing only the damaged (i.e., torn) part of 
the meniscus (i.e., APM) 90-95. For a long time, arthroscopic partial meniscectomy (APM) has 
been considered standard care for both degenerative and traumatic tears; a view based on 
the premise that APM often results in pain relief rather than evidence-based considerations 
21,95-97. APM is currently still the most performed orthopedic procedure in The Netherlands 
and in many other countries; indeed, each year over 40.000 of them are performed in our 
country 98-100. However, a shift is taking place to a more evidence-based approach, which, 
in recent years, has led to a significant change in the treatment of meniscal tears 53,96,101,102.
Of key importance in this paradigm shift are several high-quality randomized controlled 
trials (RCTs) and meta-analyses that have been published recently comparing APM with non-
operative therapy for patients with degenerative meniscal tears 103-107. Most of these have 
reported no significant difference in clinical outcome between the two treatment strategies. 
These findings, and growing concerns regarding the increased risk of developing OA after 
APM 96,108,109, have led to much discussion on the treatment of degenerative meniscal tears. 
Non-operative therapy for meniscal tears is increasingly considered a serious treatment op-
tion rather than “masterly neglect” or “leaving the meniscal tear alone” 110-112.
Figure 1. Schematic overview of the continuum theory of meniscal degeneration. During the 
course of the process from healthy meniscal tissue to meniscal degeneration (dark-blue arrow), optimal 
imaging techniques vary. Knee symptoms may occur in early phase, mid-term, late phase, or not at all. In 
this theory, a traumatic event (yellow thunderbolt-sign) can occur anywhere in the continuum and may 
accelerate the process of degeneration. The continuum potentially has a two-sided nature (light-blue 
arrow).
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A general consensus on the treatment of degenerative meniscal tears was reached in 2016 
by the European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA), 
providing a management algorithm which recommends starting with non-operative treat-
ment (comprising exercise therapy and pain medication) 113.
For many years, studies comparing operative and non-operative treatment were limited 
to degenerative meniscal tears. Consequently, very little evidence is currently available for 
the efficacy of APM for traumatic tears. To address this gap in knowledge, we designed the 
STARR trial, an RCT comparing APM to non-operative treatment (i.e., exercise therapy and 
pain medication) in patients under 45 years old with traumatic meniscal tears (described in 
Chapter 7). Other institutions, such as the University of Southern Denmark, followed by 
starting comparable trials 114. The relevance of such trials is obvious, but one should realize 
that conducting them is challenging. It often takes considerably more time than expected 
and scheduled, because of multiple factors.
As in many RCTs, a major issue in the STARR trial is the availability of eligible patients. To 
optimize methodological power, strict eligibility criteria are applied in the STARR trial. For in-
stance, only patients with a solitary meniscal tear and no additional MRI findings in the knee 
(e.g., no cartilage lesions, anterior cruciate ligament ruptures) are included. A priori estima-
tion of incidence of that specific injury was overstated and did not match reality; resulting in 
a considerable slower inclusion rate than scheduled. It is critical that, in future studies, more 
effort is taken to optimize the balance between scientific and pragmatic considerations, with 
the aim of high-quality yet feasible trials. In particular, an a priori defined realistic time frame, 
based on feasible inclusion rates, is highly relevant.
Another important issue concerning the slow inclusion rate in the STARR trial is the current 
paradigm of traumatic meniscal tear treatment, both for patients and orthopedic surgeons. 
In general, an overall consensus among clinicians has emerged that arthroscopic treatment 
is often not required for degenerative meniscal tears (although there remains a gap between 
scientific evidence and daily clinical practice). For treating traumatic meniscal tears, however, 
arthroscopy is still considered standard care by many orthopedic surgeons and by many 
patients. In general, this view has hampered their incentive to recruit patients for the STARR 
trial (as in the STARR trial, patients are randomized for either APM or non-operative treat-
ment). In particular, the presence of locking complaints in the knee is often considered a valid 
indication for APM (although exactly what “locking complaints” entail is up for debate as no 
strict definition exists). Studies suggest, however, that locking complaints do not necessarily 
require arthroscopic treatment 115,116. In fact, only a “fixed locked knee” (i.e., when a patient 
is completely unable to move the knee, generally caused by a dislocated meniscal tear) is a 
definite indication for arthroscopy 117. Despite attempts to inform and instruct surgeons and 
patients carefully regarding the importance of scientific evidence, this treatment paradigm 
for traumatic meniscal tears seems, understandably, rather persistent. The online available 
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information for patients regarding the treatment of meniscal tears might also be contributing 
to this issue. For instance, the official website of the Dutch Association for Sports Medicine, 
as well as several websites of private clinics, indicates that arthroscopic treatment is required 
in the case of a meniscal tear 118-120. This emphasizes the need for high-quality evidence 
regarding the treatment of traumatic meniscal tears.
Taking the current treatment paradigm into account, great care must be taken in imple-
menting future results of studies such as the STARR trial in clinical practice, at the patient, 
the clinician, and the society level.
Clinical decision making in meniscal pathology: evidence-based patient 
selection for APM
A great deal of variability is seen in clinical factors that orthopedic surgeons use regarding 
the decision to perform APM; however, indication is not always evidence-based 101. In this 
context, knowledge of prognostic factors for clinical outcome of APM on short-term and 
long-term could contribute to a more evidence-based patient selection for APM.
Various predictive factors for a worse clinical outcome of APM have been described in the 
literature, such as high BMI, meniscal extrusion and total meniscectomy 121,122. The literature 
review in Chapter 8 of this thesis was the first systematic review looking at prognostic 
factors for the clinical outcome after APM. We analyzed all available research describing 
clinical outcome after APM in mid-term and long-term (at least one-year follow-up). Based 
on the best available evidence, we concluded that the presence of radiographic knee OA, 
longer duration of complaints and resection of more tissue are associated with worse clinical 
outcome.
As a degenerative meniscal tear is associated with knee OA, one might expect that the clas-
sification of “degenerative versus traumatic” tears would have predictive value as well, that 
is, that degenerative tears would result in worse clinical outcome after APM. Surprisingly, 
this does not seem to be the case based on our systematic review. A possible explana-
tion for this lies in the absence of a clear and widely accepted definition of “degenerative 
tear”, as mentioned earlier. Also, the fact that a great deal of heterogeneity in the definition 
of subgroups and in outcome measures was observed across included studies might have 
played a role in this.
Our study results may contribute to the development of a prediction model for clinical 
outcomes of APM based on patient-dependent features. Such a model may be helpful in 
clinical decision making for meniscal pathology, potentially allowing a more evidence-based 
approach to patient selection for APM. In particular, the prognostic factor “presence of knee 
OA” is an interesting finding, especially with the potential of qMRI techniques, such as T2 
mapping, to detect subtle tissue changes and early stages of degeneration Chapter 2.
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It should be noted that, in this systematic review, only clinical outcome after APM was 
assessed. Although beyond the scope of our study, knowledge regarding the long-term 
radiological outcome of APM, in particular regarding the increased risk of developing OA, is 
clinically relevant as well. In addition, we did not include studies regarding meniscal repair 
but only studied prognostic factors for the outcome after APM, that is, meniscal resection. 
The rationale behind this approach was based on the clinical relevance of APM; the great 
majority of arthroscopies for meniscal tears comprise APM rather than repair.
key points for future research
•	 T2 mapping of the meniscus is a relatively new, yet highly potential technique. Proof-of-
concept of T2 mapping to assess meniscal degeneration using a standard fast spin echo 
sequence was provided in this thesis Chapter 2 and previous studies 11,12. In order to find its 
way in future implementation in clinical practice, the next step would be to confirm these 
findings in larger samples as well as in other patient groups (e.g., traumatic meniscal 
tears). In this context, we envision histology-based validation of in vivo meniscal T2 map-
ping, including the assessment of meniscal zones.
•	 Cartilage T2 mapping is shown to be capable of distinguishing degrees of OA (i.e., 
discriminative validity) and of providing longitudinal reproducibility. Hence, it has great 
potential as a non-invasive biomarker for tissue degeneration and is already used for 
longitudinal evaluation of cartilage degeneration in large clinical trials, such as the Osteo-
arthritis Initiative (OAI) 39,123. The findings regarding inter-scanner variability in T2 values 
in this thesis Chapter 3 and previous work 30-32, however, remain a matter of concern. In the 
context of future studies comprising T2 mapping in multicenter setting and, eventually, 
its implementation in clinical practice, future work on this issue is essential. Researchers 
should work together to further unravel underlying mechanisms causing the inter-
scanner differences, using large-scale T2 mapping data derived from various MRI systems 
and acquisition protocols. The ultimate goal would be a general consensus regarding 
standardized T2 mapping protocols for each scanner type. Generating comparable T2 
values across different scanner and coil types might not be realistic goal, yet standardized 
algorithms for conversion factors across scanners might be valuable.
•	 The 5-minute qDESS knee-MRI, studied in this thesis, provides diagnostic image quality 
along with quantitative T2 measurements of cartilage and meniscus in a single scan. 
Proof-of-concept 40 as well as construct validation in a clinical OA population Chapter 4 shows 
the great potential of qDESS and provide a framework for further research. An important 
challenge lies in further optimizing qDESS in a way that all relevant knee structures and 
abnormalities can be assessed accurately, especially regarding bone marrow lesions. Sub-
sequently, future studies evaluating the reliability of qDESS outcome parameters in terms 
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of longitudinal reproducibility (i.e., reliability of measuring intra-subject T2 changes over 
time) are required. In the context of future implementation in clinical practice, further 
work is needed on the diagnostic performance of qDESS images for knee assessment.
•	 Further	work	is	needed	regarding	pathophysiological processes in meniscal degeneration 
and the development and progression of knee OA. Key to all this is the interplay be-
tween relevant knee structures, such as the menisci and articular cartilage. Future studies 
should comprise multidimensional longitudinal analyses, focusing on spatial relationships 
between different knee structures and regions, and the association with biomechanical, 
inflammation, and clinical features. The approach we propose includes further investigat-
ing the causal chain of events in meniscal degeneration and the continuum theory. qMRI 
techniques such as T2 mapping will be highly valuable in this context.
•	 Regarding	 clinical	decision	making	 for	meniscal	pathology,	 it	has	become	 increasingly	
clear that the treatment goal in patients with meniscal pathology does not only com-
prises rapidly restoring knee function and relieving pain, but also satisfactory long-term 
clinical outcomes and preservation of joint health 75,113. This shift in paradigm towards 
a more evidence-based approach in clinical decision making will be enhanced by future 
study results of the STARR trial and comparable studies. Future cross-over analyses and 
knowledge of prognostic factors for the outcome of APM may provide valuable infor-
mation regarding subsets of patients who are likely to benefit from APM. Non-invasive 
assessment of tissue quality, for instance using T2 mapping, may in future help in clini-
cal decision making. Also, T2 mapping may potentially be a valuable tool to assess the 
reparability of meniscal tears on MRI and to evaluate outcomes of repair.
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Summary
The major biomechanical role of the meniscus within the knee joint and the relevance of 
meniscal integrity for the long-term health of the knee is becoming increasingly evident. In 
this thesis, several aspects of the meniscus are studied, comprising both basic science and 
clinical studies. The thesis is subdived into two main themes:
I) Magnetic resonance (Mr) imaging of the meniscus (and cartilage), with the focus 
on quantitative MRI (qMRI) techniques. The validity and reproducibility of T2 mapping, 
the most widely used qMRI technique in musculoskeletal research, are evaluated. Also, 
methods to increase efficiency in MRI acquisition of the knee, in particular regarding scan 
time, are investigated.
II) Etiology and treatment of meniscal pathology, with the aims to unravel etiologic 
processes and improve clinical decision making in meniscal pathology.
PART I: MR IMAGING OF MENISCAL PATHOLOGY
Validity and reproducibility of T2 mapping as imaging biomarker in 
musculoskeletal research
In Chapter 2, a validation study of meniscal T2 mapping is described. We prospectively 
validated in vivo T2 mapping in menisci from OA patients against histological degree of 
degeneration. In this study, 13 menisci from seven patients were collected during total knee 
replacement surgery (Figure 1) and processed for histological analysis in a standardized way. 
Measurements were performed in the anterior and posterior meniscal horns. MRI examina-
tion of the knee was acquired on a 3-T scanner, one day prior to surgery. T2 mapping analysis 
was performed using standard fast spin echo sequence with echo time values ranging from 
3-27 ms. The histological degree of degeneration was measured using a validated scorings 
system, comprising the subdomains surface integrity, cellularity, collagen structure, and ma-
trix staining (Figure 2). A strong correlation (r = 0.84, CI-95% 0.64-0.93) was found between 
T2 measurements and the histological degree of degeneration. Although the study’s sample 
size was relatively small, and it is not clear whether the results can be extended to patholo-
gies other than knee OA, these findings suggest that fast spin echo based T2 mapping can 
provide accurate T2 measurements in menisci.
In Chapter 3, reproducibility and multicenter comparability of cartilage T2 mapping was 
assessed. In the STARR trial, a clinical randomized controlled trial comparing operative and 
non-operative treatments for traumatic meniscal tears, T2 mapping is used as outcome 
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measure for early cartilage degeneration. The STARR trial is a multicenter study with eight 
participating hospitals using various MRI systems and T2 mapping sequences. To interpret 
cartilage T2 data of STARR patients, information regarding reproducibility and comparability 
of T2 values, acquired in different hospitals, will be essential. In this context, we performed 
a prospective pilot study in which cartilage T2 mapping of four traveling healthy volunteers 
and a phantom was acquired at five different hospitals in one day. Each of the five hospitals 
is a participating center in the STARR trial, using various MRI systems (from different vendors) 
and T2 mapping sequences. 
To assess longitudinal reproducibility of T2 measurements, the exact same experiment was 
performed six months later, using the same healthy volunteers. Six different cartilage regions 
of interest (ROIs) were included for each subject. Overall, the results showed a good to excel-
lent longitudinal reproducibility of cartilage T2 measurements over the six-months-interval, 
with ICCs ranging from 0.73 – 0.91 and RMS-CV values ranging from 1.1 – 1.5% for each 
ROI. Highest reproducibility was observed in the medial femoral cartilage, while lowest 
reproducibility was observed in the lateral tibial cartilage. RMS-CV values for longitudinal 
reproducibility of T2 measurements for each hospital ranged from 0.6 – 1.6%. Due to the low 
sample size, ICCs for each center/hospital could not be reliably calculated. Lowest RMS-CVs 
(indicating highest reproducibility) were observed in Philips 3-Tesla and GE 3-Tesla scanners.
Cross-validation of T2 measurements in this multicenter pilot study (Chapter 3) revealed 
significant differences in T2 values across hospitals, both in vivo and in the phantom, similar 
to previous multicenter studies on T2 mapping. Though outside the scope of the present 
thesis, underlying mechanisms in the T2 differences across centers need to be unraveled. For 
now, we conclude that cartilage T2 values from different hospitals should not be assumed to 
be comparable and should not be pooled.
Feasibility of (q)Mri: reducing scan time
Routine MRI examination of the knee, especially when adding quantitative imaging, generally 
takes up to 30-45 minutes. By providing quantitative measures of cartilage and meniscus and 
diagnostic image quality in a single MRI scan with an acquisition time less than five minutes, 
the recently developed quantitative double-echo steady-state (qDESS) MRI sequence for the 
knee has the potential to drastically reduce scan time. A single, rapid scan such as qDESS 
holds great promise, in particular, for longitudinal and large-scale clinical studies.
In Chapter 4, a validation study on qDESS is reported. Building upon a recently published 
proof-of-concept study of qDESS, we validated this new and promising technique in a clini-
cal knee OA population (Figure 3). qDESS-based T2 mapping of cartilage and menisci and 
structural (semi-quantitative) knee assessment in 53 subjects with different degrees of knee 
OA were found to be statistically significantly correlated with radiographic knee OA. Mean 
cartilage T2 values were 36 ms in subjects without OA, 41 ms in those with mild OA, and 47 
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ms in those with moderate OA. Mean meniscal T2 values were 15 ms in subjects without OA, 
18 ms in those with mild OA, and 21 ms in those with moderate OA. T2 measurements were 
found to be comparable with T2 values in the literature. Although further research to optimize 
and validate qDESS is greatly needed, our findings show the potential value of qDESS.
PART II: ETIOLOGY AND TREATMENT OF MENISCAL PATHOLOGY
Etiology of meniscal pathology
In Chapter 5, the role of the meniscus in the development of knee OA, in particular the 
interplay between cartilage and meniscus degeneration, was studied in a mouse OA model. 
Histological degree of degeneration of menisci and cartilage was assessed at different time 
points during the course of OA (1, 3, 7, 14, 28 and 56 days after OA was induced). Also, 
meniscal extrusion (i.e., radial displacement of the meniscus) was evaluated at each time 
point. We found that cartilage and meniscus degeneration appeared around the same time 
(14 – 28 days after OA was induced) and that they were moderately correlated with each 
other. Moreover, meniscal extrusion was seen from day 1 onwards, suggesting that meniscal 
extrusion may represent early OA.
In Chapter 6, the etiology of meniscal pathology was investigated taking a clinical ap-
proach. We challenged the traditional classification of “traumatic” versus “degenerative” 
meniscal tears. We tested the theory that, instead of a clear-cut classification of traumatic and 
degenerative tears, a continuum of degeneration exists. Our hypothesis was that traumati-
cally torn meniscal tissue shows more degeneration than intact tissue. A secondary aim was 
to identify patient specific factors that are associated with a higher degree of degeneration. 
In this histology-based study, meniscal tissue from patients with traumatic meniscal tears 
(obtained during arthroscopy, Figure 4) was compared to intact menisci (obtained during 
traumatic trans-femoral amputation or post-mortem). Meniscal tissue from patients with 
knee OA, obtained during total knee replacement surgery, was used as reference standard 
for degenerative menisci. After adjustment for sex, age, BMI, and time interval between 
trauma and surgery, patients with a traumatic meniscal tear showed a statistically signifi-
cantly higher histological degree of degeneration than patients with intact meniscal tissue. 
No statistically significant difference in histological score was found between the traumatic 
and osteoarthritic group. In the traumatic group, no association between the degree of 
degeneration and time interval between trauma and surgery was observed. Moreover, no 
association was observed between degree of degeneration and the factors “age” and “sex”. 
A statistically significant positive correlation between the patient specific factor “BMI” and 
histological degree of degeneration was found. Our findings support the continuum theory; 
however, further research is required on the etiology of meniscal pathology and the exact 
pathways from healthy meniscal tissue to degenerated meniscal tissue.
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Clinical decision making in meniscal pathology
Although arthroscopic partial meniscectomy (APM) is the most performed orthopedic proce-
dure in most western countries, no evidence is available comparing APM with non-operative 
treatment for traumatic meniscal tears. Therefore, we have designed and conducted the 
STARR trial, a multicenter randomized controlled trial (RCT), in which APM and non-operative 
(i.e., exercise) therapy are compared in patients aged 45 years or younger with traumatic 
meniscal tears. In Chapter 7, the design of the STARR trial is described. In total, 100 patients 
are included in the trial. After randomization, STARR patients are followed for two years, to 
investigate the differences between APM and exercise therapy in 1) clinical outcome (pain 
and function of the knee), 2) early signs of cartilage and meniscus degeneration on qMRI, 
and 3) cost-effectiveness of the treatments. The STARR trial is still ongoing, the results will be 
available at the end of 2020.
To increase evidence-based clinical decision making for meniscal tears, knowledge of 
prognostic factors for treatment outcomes is essential. In Chapter 8, a systematic review 
is presented on prognostic factors for the clinical outcome after APM. The study design of 
this review was in accordance with the Preferred Reporting Items for Systematic Reviews 
and Meta-analyses (PRISMA) recommendations {Moher 2009}. Together with the biomedical 
literature specialist of our medical library, we systematically searched Medline, Embase, Co-
chrane, Web of Science, SPORTDiscus, Pubmed Publisher and Google Scholar databases, and 
article references. Articles reporting an association between patient-related or intra-articular 
factors and clinical outcome of APM, using validated questionnaires and with minimum 
follow-up of one year were included. Screening and quality assessment of selected studies 
was performed by two researchers independently. Out of 5150 potential eligible articles, 
identified by the search, 32 studies were included in this systematic review, comprising in 
total 4250 patients with a follow-up ranging from 1 to 13 years. Pooling the data was not 
appropriate due to considerable heterogeneity in the study population, subgroup definition, 
and outcome measures across included studies. Instead, a Best Evidence Synthesis was per-
formed, by summarizing findings of included studies while taking the weight of the evidence 
into account. Moderate evidence was found showing that longer duration of symptoms 
(longer than one year), the presence of radiographic knee OA at baseline, and resecting more 
meniscal tissue during APM, are predictors for worse clinical outcome. Moreover, moderate 
evidence suggested that sex, pre-operative sport level, onset (i.e., traumatic versus degenera-
tive), and type of meniscal tear are not prognostic factors for the clinical outcome after APM.
Chapter 9 comprises a general discussion encompassing the study results in this thesis. 
Moreover, clinical implications and future research perspectives are provided.
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Figure 1. Preparation of meniscal samples. Example of a lateral meniscus harvested during total knee 
arthroplasty in a left knee of a 59-year-old female with medial compartment knee OA. A) Vertical cut. B) 
Horizontal cut. C) Detail view of vertical cut of the posterior horn.
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Figure 2. Histological fi ndings in meniscal tissue and T2 mapping images. A, C, E) Posterior horn 
of lateral meniscus of 67-year-old female with mild OA. B, D, F) Posterior horn of medial meniscus of 
66-year-old female with severe OA. A, B) Surface integrity. C, D) Collagen organization. I, J) Correspond-
ing T2 mapping images with meniscal color maps.
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Figure 4. Harvesting and processing meniscal tissue. A) Harvesting of intact menisci in 53-year-old 
male during transfemoral amputation. B) Macroscopic view of medial meniscus after harvesting. C) 
Vertical cut of medial posterior horn. D) Corresponding histological section (HE staining). E) Harvesting 
of traumatically torn meniscal tissue in 39-year-old male during arthroscopic partial meniscectomy. F) 
Meniscal tissue after harvesting (medial meniscus). G) Vertical cut. H) Corresponding histological section 
(HE staining).
 
 
 
 
 
 
 
 
 
  
A B C 
Figure 3. representative example of sagittal qDESS images in 37-year-old female without OA, 
lateral knee compartment. A) First qDESS echo, TE 5.7 ms. B) Second qDESS echo, TE 30.1 ms. C) Cor-
responding T2 color maps of cartilage and meniscus.
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Nederlandse samenvatting
Er wordt steeds meer duidelijk over de belangrijke biomechanische rol van de meniscus bin-
nen het kniegewricht en het belang van een goed werkende meniscus voor een gezonde 
knie functie op de lange termijn. In dit proefschrift komen verschillende aspecten van de 
meniscus aan bod, zowel binnen de basale wetenschap als binnen het klinisch onderzoek. 
Het proefschrift is onderverdeeld in twee hoofd thema’s:
I) Magnetic resonance (Mr) imaging van de meniscus (en kraakbeen), met de focus 
op kwantitatieve MRI (qMRI) technieken. De validiteit en reproduceerbaarheid van T2 
mapping, de meest gebruikte qMRI techniek in musculoskeletaal onderzoek, zijn geëva-
lueerd. Ook zijn er methoden onderzocht om de efficientië van MRI acquisitie van de knie 
te verhogen, met name gericht op het reduceren van scantijd.
II) Etiologie en behandeling van meniscus pathologie, met het doel om meer duidelijk-
heid te verkrijgen over etiologische processen en het verbeteren van ‘’clinical decision 
making’’ voor meniscus pathologie.
DEEL I: MR IMAGING vAN MENISCuS PATHOLOGIE
Validiteit en reproduceerbaarheid van T2 mapping als imaging biomarker 
in musculoskeletaal onderzoek
In Hoofdstuk 2 wordt een validatie studie naar meniscus T2 mapping beschreven. We 
hebben in vivo T2 mapping in menisci van artrose patiënten prospectief gevalideerd tegen 
histologische mate van degeneratie. In deze studie zijn 13 menisci van zeven patiënten 
verzameld tijdens totale knie vervangende chirurgie (Figuur 1 van Summary) en verwerkt 
voor histologische analyse op gestandardizeerde wijze. Metingen zijn verricht in de meniscus 
voor- en achterhoorn. MRI van de knie werd verricht op een 3-T scanner, een dag voor de 
operatie. T2 mapping analyse werd verricht met een standaard fast spin echo sequence met 
echo tijden tussen de 3-27 ms. De histologische mate van degeneratie werd gemeten met 
een gevalideerd scorings systeem, bestaande uit de subdomeinen: oppervlakte integriteit, 
cellulariteit, collageen structuur, en matrix aankleuring (Figuur 2 van Summary). Een sterke 
correlatie (r = 0.84, CI-95% 0.64-0.93) werd gevonden tussen T2 waarden en histologische 
mate van degeneratie. Hoewel de sample size van de studie relatief klein is en het niet 
zeker is of de resultaten geëxtrapoleerd kunnen worden naar andere aandoeningen dan knie 
artrose, suggereren deze resultaten dat met fast spin echo-based T2 mapping accurate T2 
metingen in menisci verkregen kunnen worden als maat voor degeneratie.
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In Hoofdstuk 3 is er gekeken naar reproduceerbaarheid en vergelijkbaarheid van T2 map-
ping in kraakbeen. In de STARR trial, een klinische gerandomiseerde trial waarbij operatieve 
en niet-operatieve behandeling van traumatische meniscusscheuren worden vergeleken, 
wordt T2 mapping gebruikt als uitkomstmaat voor vroege kraakbeen- en meniscus schade. 
De STARR trial is een multicenter trial waarin acht ziekenhuizen participeren, met verschil-
lende MRI systemin en T2 mapping protocollen. Om de T2 data van kraakbeen en menisci 
te kunnen intepreteren is kennis met betrekking tot reproduceerbaarheid en multicenter 
vergelijkbaarheid van T2 waarden, afkomstig uit verschillende ziekenhuizen, essentieel. In 
dit kader hebben wij een prospectieve pilot studie uitgevoerd waarbij kraakbeen T2 waarden 
van vier gezonde vrijwilligers en een fantoom, gescand in vijf verschillende ziekenhuizen 
(allemaal op dezelfde dag), werden vergeleken. Het ging hierbij om STARR-gelieerde centra 
met verschillende MRI systemen.
Om de reproduceerbaarheid van T2 metingen over de tijd te beoordelen, werd een identiek 
experiment zes maanden na de baseline metingen uitgevoerd, met dezelfde gezonde vrijwil-
ligers. Zes verschillende kraakbeen regio’s werden geïncludeerd per knie. Over het algemeen 
laten de resultaten een goede tot uitstekende reproduceerbaarheid van T2 metingen zien 
over het zes-maanden-interval, met ICCs varierend van 0.73 – 0.91 en RMS-CV waarden van 
1.1 – 1.5%. De hoogste reproduceerbaarheid werd gezien in het mediale femur kraakbeen, 
het laterale tibia kraakbeen scoorde het laagst. RMS-CV waarden voor de reproduceerbaar-
heid van T2 metingen over de tijd voor elk ziekenhuis apart varieerden van 0.6 – 1.6%. De 
laagste RMS-CV waarde en dus de hoogste reproduceerbaarheid werd gevonden in Philips 
3-Tesla en GE 3-Tesla scanners. Door de lage aantallen (n = 4) was het niet mogelijk om op 
betrouwbare wijze ICCs voor elk ziekenhuis apart te berekenen.
Cross-validatie van T2 metingen in de betreffende multicenter pilot studie (Hoofdstuk 3) 
liet significante verschillen in T2 waarden tussen ziekenhuizen zien, zowel in vivo als in het 
fantoom, vergelijkbaar met eerdere multicenter studies over kraakbeen T2 mapping. Hoewel 
buiten de scoop van het huidige onderzoek, is het van belang de onderliggende mechanis-
men achter de gevonden verschillen in T2 waarden tussen ziekenhuizen te onderzoeken. Voor 
nu concluderen we dat kraakbeen T2 waarden, verkregen uit verschillende ziekenhuizen, niet 
zonder meer vergeleken danwel gepooled mogen worden.
reduceren van scantijd bij qMri
Een MRI scan protocol voor de knie, inclusief kwantitatieve metingen, duurt momenteel ca. 
30-45 minuten. De recent ontwikkelde quantitative double-echo steady-state (qDESS) MRI 
techniek voor de knie combineert diagnostische beeldkwaliteit met kwantitatieve metingen 
van kraakbeen en meniscus in een enkele MRI scan met acquisitie tijd van minder dan vijf 
minuten. qDESS heeft hierdoor de potentie om scantijd drastich te reduceren. Deze techniek 
is veelbelovend, In het bijzonder voor longitudinale en/of grootschalige klinische studies.
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In Hoofdstuk 4 wordt een validatie studie naar qDESS beschreven. Voortbordurend op 
een recent gepubliceerde qDESS proof-of-concept studie, hebben we deze innovatieve 
techniek gevalideerd in een klinische knie artrose populatie (Figuur 3 van Summary). Met 
qDESS verkregen T2 mapping van kraakbeen en menisci en structurele (semi-kwantitatieve) 
knie scores in 53 patiënten met verschillende gradaties knie artrose waren statistisch signi-
ficant gecorreleerd aan radiologische mate van artrose. Gemiddelde kraakbeen T2 waarden 
waren 36 ms in personen zonder artrose, 41 ms in patiënten met milde artrose, en 47 ms 
in patiënten met matige artrose. De gemiddelde meniscus T2 waarden bedroegen 15 ms in 
personen zonder artrose, 18 ms in patiënten met milde artrose, and 21 ms in patiënten met 
matige artrose. De gevonden T2 waarden bleken redelijk overeen te komen met T2 waarden 
uit de literatuur. Onze resultaten laten de potentiële waarde en toepasbaarheid van qDESS 
voor knie artrose zien; nadere optimalisatie van de techniek en validatie van qDESS in grotere 
groepen en andere pathologie is uiteraard noodzakelijk.
DEEL II: ETIOLOGIE EN bEHANDELING vAN MENISCuS 
PATHOLOGIE
Etiologie van meniscus pathologie
Hoofdstuk 5 beschrijft een studie naar de rol van de meniscus in het ontwikkelen van knie 
artrose, in het bijzonder de wisselwerking tussen kraakbeen en meniscus degeneratie, in 
een muis model. De histologische mate van degeneratie van menisci en kraakbeen werd 
beoordeeld op verschillende tijdpunten gedurende de ontwikkeling van knie artrose (1, 3, 7, 
14, 28 en 56 dagen na artrose inductie). Ook werd de mate van meniscus extrusie (d.w.z. de 
zijwaartse verplaatsing van de meniscus) geëvalueerd op elk tijdpunt. Onze resultaten lieten 
zien dat kraakbeen en meniscus degeneratie rond dezelfde tijd ontstaat (14 – 28 dagen na 
artrose inductie) en dat deze matig gecorreleerd zijn aan elkaar. Meniscus extrusie werd 
gezien vanaf dag 1 na artrose inductie, suggererend dat meniscus extrusie mogelijk vroege 
artrose representeert.
In Hoofdstuk 6 hebben we de etiologie (d.w.z. onstaanswijze) van meniscus pathologie 
onderzocht vanuit een klinisch perspectief, waarbij de traditionele classificatie van “trauma-
tische” versus “degeneratieve” meniscus scheuren betwist werd. Onze hypothese was, dat 
in plaats van een dichotome classificatie tussen traumatische en degeneratieve scheuren, er 
een continuüm van degeneratie bestaat. In dit continuüm loopt de mate van degeneratie op 
in een cascade van gezond meniscus weefsel tot degeneratief weefsel, waarbij de kans op 
een meniscus scheur bij knietrauma toeneemt bij meer degeneratie. In ons onderzoek werd 
meniscus weefsel van patiënten met traumatische meniscus scheuren (verkregen tijdens 
arthroscopie, Figuur 4 van Summary) vergeleken met intacte gezonde menisci (verkregen 
tijdens traumatische bovenbeenamputaties of post mortem). Meniscus weefsel van knie 
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artrose patiënten (verkregen tijdens knie vervangende chirurgie) werd gebruikt als referentie 
meting voor degeneratief weefsel. Na correctie voor geslacht, leeftijd, BMI en tijdinterval 
tussen trauma en operatie, vertoonden patiënten met traumatische meniscus scheuren 
een statistisch significant hogere mate van degeneratie dan patiënten met intact meniscus 
weefsel. Geen statistisch significant verschil in mate van degeneratie werd gevonden tussen 
traumatisch gescheurd en degeneratief weefsel. In de groep met traumatisch gescheurd 
weefsel werd geen verband gevonden tussen het tijdinterval tussen trauma en operatie en 
mate van degeneratie. Ook werd er geen significant verband gezien tussen de mate van 
degeneratie en de factoren geslacht en leeftijd. Wel werd er een statistisch significante corre-
latie gevonden tussen het BMI van de patiënt en de mate van degeneratie. Onze bevindingen 
ondersteunen de continuüm theorie en bieden aanknopingspunten voor verder onderzoek. 
De pathofysiologische mechanismen die een rol spelen bij de cascade van gezond meniscus 
weefsel tot degeneratief weefsel, en het onderscheid tussen artrose- versus ouderdoms-
gerelateerde weefsel degeneratie zijn hierbij belangrijke invalshoeken.
‘’Clinical decision making’’ voor meniscus pathologie
Hoewel arthroscopische partiële meniscectomie (APM) de meest verrichte orthopedi-
scheingreep is in westerse landen, is er geen wetenschappelijk bewijs beschikbaar voor 
de effectiviteit van APM ten opzichte van niet-operatieve behandeling van traumatische 
meniscus scheuren. Om dit kennishiaat op te vullen hebben we vanuit het Erasmus MC in 
2014 de STARR trial geïnitieerd, een multicenter randomized controlled trial (RCT), waarin 
APM en niet-operatieve behandeling (fysiotherapie) worden vergeleken in patiënten onder 
de 45 jaar met traumatische meniscus scheuren. In Hoofdstuk 7 wordt het studieprotocol 
van de STARR trial beschreven. In totaal zijn er 100 patiënten geïncludeerd in de trial. Na 
randomizatie worden STARR patiënten voor twee jaar gevolgd, om de verschillen tussen APM 
en fysiotherapie te onderzoeken met betrekking tot 1) klinische uitkomst (pijn en functie) 2) 
vroege tekenen van knie artrose op qMRI, en 3) kosten-effectiviteit van de behandelingen. 
De STARR trial is nog lopende, de resultaten zullen eind 2020 beschikaar zijn.
Om een meer ‘evidence-based’ clinical decision making voor meniscus letsel te faciliteren, 
is kennis van prognostische factoren voor therapie uitkomsten essentieel. Hoofdstuk 8 be-
schrijft een systematisch literatuuronderzoek naar prognostische factoren voor de klinische 
uitkomst na APM. Het studie ontwerp van dit review was in overeenstemming met de Prefer-
red Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) aanbevelingen. Sa-
men met de biomedisch literatuur specialist van onze medische bibliotheek doorzochten we 
op systematische wijze de databases Medline, Embase, Cochrane, Web of Science, SPORT-
Discus, Pubmed Publisher en Google Scholar databases, en artikel referenties. Artikelen die 
een associatie tussen patiënt-gerelateerde of intra-articulaire factoren en klinsche uitkomst 
van APM rapporteerde, waarbij gebruik werd gemaakt van gevalideerde vragenlijsten en 
met minimaal een jaar follow-up werden geïncludeerd. Screening en kwaliteitscontrole van 
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de geselecteerde studies werd verricht door twee onderzoekers, onafhankelijk van elkaar. 
Uit 5150 potentieel geschikte artikelen, geïdentificeerd door de database search, werden 
er 32 studies geïncludeerd in dit systematische review, in totaal 4250 patienten omvattend 
met een follow-up duur tussen de 1 en 13 jaar. Pooling van de data was niet mogelijk door 
aanzienlijke heterogenitieit in de studie populatie, in subgroep definities, en in uitkomst 
maten tussen geïncludeerde studies. Er werd daarom een ‘’Best Evidence Synthesis’’ verricht, 
waarbij bevindingen van geïncludeerde studies werden geanalyseerd gebruik makend van 
een weegfactor voor de bewijskracht van de studies. Er werd matig bewijs gevonden voor 
de voorspellende waarde van een langere duur van klachten (meer dan een jaar), voor de 
aanwezigheid van radiologische artrose ten tijde van de operatie en voor het peroperatief 
verwijderen van meer meniscus weefsel op een slechtere klinische uitkomst. Ook werd er 
matig bewijs gevonden dat geslacht, pre-operatief sport niveau, ontstaanswijze (traumatisch 
versus degeneratief), en type scheur geen prognostische factoren zijn voor de klinische 
uitkomst na APM.
Hoofdstuk 9 omvat een algemene discussie van de studieresultaten in dit proefschrift. Tevens 
worden er klinische implicaties en perspectieven voor toekomstig onderzoek beschreven.
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List of abbreviations
ACL = Anterior cruciate ligament
ACR = American College of Rheumatology
ANOVA = Analysis of variance
APM = Arthroscopic partial meniscectomy
BMI = Body mass index
CIOA = Collagenase-induced osteoarthritis
CONSORT= Consolidated Standards of Reporting Trials
DMM = Destabilization of the medial meniscus
FSE = Fast spin echo
FSPGR = Fast-spoiled gradient-echo
ICC = Intraclass correlation coefficient
IKDC = International Knee Documentation Committee
ICRS = International Cartilage Repair Society
IQR = Inter quartile range
KLG = Kellgren and Lawrence grade
KOOS = Knee injury and Osteoarthritis Outcome Score
MOAKS = MRI osteoarthritis knee score
MR = Magnetic resonance
NRS = Numeric rating scale
OA = Osteoarthritis
PRISMA = Preferred Reporting Items for Systematic Review and Meta-analysis Protocols
Prospero = International Prospective Register for Systematic Reviews
qDESS = Quantitative double-echo steady-state
qMRI = Quantitative magnetic resonance imaging
RCT = Randomized controlled trial
RMS-CV = Root mean square of coefficient of variation
ROI = Region of interest
SD = Standard deviation
SE = Spin echo
SPIRIT = Standard protocol items: recommendation for interventional trials
SNR = Signal-to-noise ratio
TE = Echo time
3-T = 3 Tesla
95%-CI = 95% confidence interval
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